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This study explored the relationships between common measures of symptom validity and a 
well-validated measure of auditory and visual memory.  An understanding of the relationships could 
result in greater accuracy of psychological assessments or even reduced administration time if 
redundancy is found.  Symptom validity and memory test measures were examined through descriptive 
statistics, multivariate regressions, and correlations.  The research design and obtained data suggest that 
performance on memory measures cannot be predicted based upon symptom validity test performance 
for a sample of undergraduate students instructed to provide full effort.  Furthermore, this study was 
unable to detect differences in the relationships between specific symptom validity measures and 
analogous measures of memory. 
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Extended Abstract 
 
 
 Symptom validity measurement is an important topic in psychological and neuropsychological 
assessment as providing accurate results is an ethical obligation (American Psychological Association, 
2010, para. 1) and can significantly influence the likelihood of an examinee receiving life-changing 
benefits or consequences (Slick, Tan, Sherman, & Strauss, 2011).  The primary purpose of the present 
study was to explore the relationship between two popular symptom validity measures, the TOMM and 
WMT, with a widely used measure of memory, the WMS-IV.  This study was conducted as a better 
understanding of the relationship between these measures could result in increased confidence in 
obtained assessment results or even allow for eliminating unneeded measures from an assessment 
battery.  A battery of neuropsychological tests, including the TOMM, WMT, and WMS-IV, was 
administered to 46 undergraduate students.  Participants were instructed to provide full effort.  
Obtained data was analyzed through descriptive statistics as well as multivariate regression and 
correlational analyses.  Nonsignificant regression findings between memory and symptom validity tests 
were found.  Uncorrected correlations between measures were moderate to large.  The findings 
underscore the need to carefully design studies and apply suitable statistical tests.  Limited variability 
on symptom validity test performance, small sample size, and usage of methods to reduce false 
positives are discussed.  The data suggests that, for this sample, symptom validity tests were ineffective 
in predicting memory performance.  Furthermore, symptom validity tests and analogous components of 
memory measures do not have a differing relationship compared to other measured memory domains. 
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Chapter I 
 
 
 
Introduction 
Many definitions of the word “malingering” can be found in the scientific literature.  Modern 
definitions tend to define malingering as a practice of intentionally modifying or misrepresenting one’s 
own behavior for purposes of feigning or fabricating symptoms associated with a particular disorder or 
disease; individuals engaging in this behavior do so to avoid an external punishment or acquire an 
external incentive (Slick, Tan, Sherman, & Strauss, 2011; American Psychiatric Association, 2013).  
Most of the current definitions of malingering have relatively subtle differences in wording.  Slick, 
Tan, Sherman, & Strauss (2011) have defined malingering as: 
The exaggeration and/or fabrication of deficits in malingering is a volitional behavior directed 
toward a substantial external incentive, either the acquisition of something desired or the 
escape from an undesirable duty, obligation, or punishment (p. 460). 
The American Psychiatric Association in the Diagnostic and Statistical Manual of Mental 
Disorders – 5th Edition (DSM-5; American Psychiatric Association, 2013) have defined malingering as: 
The essential feature of malingering is the intentional production of false or grossly exaggerated 
physical or psychological symptoms, motivated by external incentives such as avoiding 
  
SYMPTOM VALIDITY AND MEMORY 
 
10 
 
military duty, avoiding work, obtaining financial compensation, evading criminal 
prosecution, or obtaining drugs. 
The wording in the two prevalent definitions presented above demonstrate a large agreement in 
defining malingering; however, research is still exploring the possibilities of malingering being a 
mental disorder.  The American Psychiatric Association in the DSM-5 (2013) noted that malingering is 
not a mental disorder; however, some researchers (e.g. Raine, 2003) have argued that malingering fits 
the criteria of a mental disorder better than some of the other recognized mental disorders.  
Interest in malingering has been increasing in recent years.  Carone and Bush (2013) have 
suggested that scholarly attention to malingering has substantially increased in the last two decades.  In 
clinical neuropsychology, the beginning of this scholarly attention to malingering appears to have been 
set in motion in 1978 with Heaton, Smith, Lehman, and Vogt’s article, “Prospects for faking believable 
deficits on neuropsychological testing.”  In this article, Heaton and colleagues (1978) provided 
evidence that neuropsychologists’ clinical intuition alone may be insufficient for detecting malingering.  
In the study, it was found that neuropsychologists’ performance in classifying simulated malingerers 
was only marginally better than chance. 
Rationale of the Study 
Historically, it is clear that malingering has been present for aeons.  Developments throughout 
human history, particularly the increasing availability of welfare support since the 1880’s (see Wessely, 
2003), has ushered in the culmination of interest that has been demonstrated in the neuropsychological 
literature in recent decades.  Currently, all psychologists and neuropsychologists who are cognizant of 
current law and ethical code have some level of interest in topics relating to symptom validity and 
malingering as all psychologists are required to strive for accuracy throughout the evaluative process.  
The American Psychological Association noted in standard 9.01 of the Ethical Principles of 
Psychologists and Code of Conduct: 
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Psychologists base opinions contained in their recommendations, reports and diagnostic or 
evaluative statements, including forensic testimony, on information and techniques 
sufficient to substantiate their findings (American Psychological Association, 2010, 
para. 1). 
Clinicians engaging in neuropsychological evaluation may have an even greater onus to 
produce accurate results as these evaluations may result in significant financial gains or losses.  
Toomey, Kucharski, and Duncan (2009) note that in legal proceeding, the results of these evaluations 
could impede necessary treatment, influence the sentencing of an individual, or result in a defendant 
being acquitted by reason of insanity.   
While neuropsychologists following the ethical code of the American Psychological 
Association strive for accuracy in their work, it is clear that not all neuropsychologists routinely 
employ standalone measures specifically designed to assess symptom validity.  For example, Sharland 
and Gfeller (2007) found that a little more than half of a sample of National Academy of 
Neuropsychology professional members (n = 712) frequently used measures of symptom validity 
during their evaluations.  For neuropsychologists who are involved in addressing financial 
compensation claims or personal injury litigation, about 79% employed tests of symptom validity 
(Slick, Tan, Strauss, and Hultsch, 2004).  Standalone measures of symptom validity may not be 
employed for a variety of reasons.  In some cases, these measures may not be deemed necessary as 
there is no apparent noteworthy incentive for examinees to provide suboptimal effort.  In some cases, 
cost or availability of these measures may be prohibitive.  O’Bryant, Engel, Kleiner, Vasterling, and 
Black (2007) noted that these standalone measures of symptom validity are underutilized in part 
because of the significant administration time required. 
Because of the administration time required for some standalone measures of symptom validity, 
it is of interest to find ways to assess symptom validity with minimal time commitment.  A number of 
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researchers have attempted to look for patterns in commonly administered psychological and 
neuropsychological assessments in hopes of finding objective and reliable ways of assessing symptom 
validity.  Finding these “embedded validity indicators” in commonly used assessments is a very 
important task as practitioners may be able to efficiently and accurately measure symptom validity via 
information that may be readily available in a routine neuropsychological examination (Novitski, 
Steele, Karantzoulis, & Randolph, 2012).  The potential increases in evaluation accuracy and the sheer 
time-savings available by creating and understanding embedded validity indicators provide a strong 
rationale for continuing studies in this area. 
Many individuals who malinger claim to have impaired memory and it has been recommended 
that clinicians consider using tests that appear to measure memory for the purposes of assessing 
symptom validity (Lezak, Howieson, & Loring, 2004).  The current study explored how performance 
on one of the newest widely used measures of memory, the Wechsler Memory Scale, Fourth Edition 
(WMS-IV; Wechsler, 2009) related to some of the most widely known standalone measures used for 
assessing symptom validity: the Test of Memory Malingering (TOMM; Tombaugh, 1996), and the 
Word Memory Test (WMT; Green, 2003).  Part of the rationale of the study was to add to the research 
base on how current measures of memory and symptom validity compare.  In standard 9.01 of the 
American Psychological Association’s code of ethics (defined in a prior paragraph), it is noted that 
psychologists need to base their conclusions on data from techniques that provide the necessary data.  
The current study provided statistical data on how measured memory performance relates to an 
examinee’s measured symptom validity; it also provided data on how one of the most recent validated 
measures of memory, the WMS-IV, related to some of the most commonly used measures for assessing 
symptom validity, the TOMM and WMT.   
A related rationale for the current study could be determining if subtests from the WMS-IV and 
the WMT and TOMM are in fact measuring the same construct.  If the relationship between 
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performance on subtests of the WMS-IV and the WMT and TOMM relate too strongly, a jangle fallacy 
may be identified.  The jangle fallacy, as described by Kelley (1927), is a situation where multiple 
labels are used to describe the same underlying construct.   
 
Significance of the Study 
  The study explored the utility of using performance patterns in a commonly utilized measure of 
memory, the information obtained from assessment with the WMS-IV, to compare performance to 
standalone measures of symptom validity, the TOMM and WMT.  Understanding the relationship 
between these measures could provide a significant contribution to the field of neuropsychology as 
practitioners may be better informed as to how examinees’ performance on a commonly used memory 
measure could relate to performance on standalone measures of symptom validity.  This knowledge 
could save practitioners valuable evaluation time and improve the accuracy of evaluation conclusions 
by providing insight into the necessity of using additional standalone measures.  Establishing 
relationships between performance on the WMS-IV, TOMM, and WMT, could provide a useful segue to 
the establishment of practical validity indicators.   
The study explored what standalone measures may be more useful or appropriate when using 
the WMS-IV.  The WMS-IV contains subtests that measure visual memory and subtests that specifically 
measure auditory memory.  Standalone measures of symptom validity such as the WMT and TOMM 
contain tasks that appear to measure visual or auditory memory.  With this information in mind, an 
exploration of how the visual and auditory memory subtests of the WMS-IV relates to the WMT and 
TOMM could reveal interesting relationships.  Knowledge of these relationships could be useful to 
neuropsychologists as it would imply that suspect performance on certain parts of the WMS-IV could 
warrant usage of a specific standalone symptom validity test.    
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Study Procedures 
 The study used data which was obtained from a larger neuropsychological dataset.  All data was 
obtained from college students participating in a psychology research pool.  Data utilized in the study 
was from standard administrations of the TOMM, WMT, and WMS-IV.   
Research Questions 
R1 How much variance in the WMS-IV subtests does the TOMM account for? 
R2 How much variance in the WMS-IV subtests does the WMT account for? 
R3 How much variance in the WMS-IV composites does the TOMM account for? 
R4 How much variance in the WMS-IV composites does the WMT account for? 
R5 Does the examination of the means of all variables in the obtained sample look comparable to the 
means found in the literature? 
R6 How much correlation is present between TOMM and WMT scores? 
R7 How much correlation is present between WMS-IV, TOMM, and WMT scores? 
Limitations of the Study 
 One of the largest limitations to the current study is related to the nature of the sample used.  By 
using a convenience sample of college student who were predominantly healthy young adults without 
substantial incentive to give full effort or reduced effort, it is unknown how the obtained data for the 
current study would generalize to clinical populations suspected of malingering.  The sample of 
students who participated in the current study differed from many clinical populations on demographic 
factors such as age, gender, and level of education.  The sample of students who participated in the 
study was obtained from a research participant pool from one university in the Midwest.  Participants 
were offered research participation credit for an undergraduate psychology class; however, participants 
were allowed to withdraw and still receive participation credit. 
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 During the study, participants were asked to give full effort although there was no incentive or 
penalty related to the actual amount of effort given.  With data obtained in the current study, it cannot 
be determined whether or not the relationships amongst the variables in the WMT, TOMM, and WMS-
IV would differ for participants engaged in simulated malingering or examinees engaged in actual 
malingering.  Elucidating relationships between measures were complicated by the fact that the range 
of performance from the sample resulted in very little variability in symptom validity test scores.  Little 
variability in symptom validity scores impeded the establishment of relationships between the measures 
used in the study.  
Delimitations of the Current Study 
The current study utilized some of the most highly regarded measures of memory and symptom 
validity.  The WMS-IV, TOMM, and WMT have either existed for over a decade or have had earlier 
versions in existence for over a decade.  The sheer number of studies and practitioners who routinely 
use these measures in practice could attest to the quality of these instruments. 
Unlike in field studies, the circumstances for taking neuropsychological assessments in the 
current study are uniform.  All participants in the current study were engaged in the assessments for the 
purposes of fulfilling research participation requirements related to a class.  These participants very 
likely had uniform incentive for participation and presumably put forth similar levels of effort.  The 
consistency in the circumstances for assessment administration and incentive suggested that the 
findings are reliable and replicable.   
List of Terms 
Amnestic Mild Cognitive Impairment (aMCI): Amnestic Mild Cognitive Impairment (aMCI) 
consists of memory complaints, isolated memory dysfunction, intact cognitive functioning, adequate 
activities of daily living, and no significant evidence of dementia (Mariani, Monastero, & Mecocci, 
2007). 
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Coaching: In the context of neuropsychological assessment, coaching is a type of counseling that may 
encourage exaggeration of symptoms, feigning of symptoms, or resistance and defensiveness during 
the assessment.  Coaching can include test coaching, symptom coaching, or a combination of coaching 
(Powell, Gfeller, Hendricks, & Sharland, 2004).   
Cut Score / Cutting Score / Cut-off score: In the context of symptom validity tests, a cut score is a 
performance cut-off score that can provide an examiner with data on the likelihood of the examinee 
providing sufficient on a test.  Cut scores are designed to minimize false positive diagnoses for 
examinees providing legitimate effort while accurately detecting low effort as much as possible 
(Larrabee, 2003).   
Dementia: Dementia often refers to degenerative dementias (e.g. Alzheimer’s Disease) that often 
impact older populations although it could refer to other cognitive declines by some definitions;   
Dementia is considered to be a major neurocognitive disorder (DSM-5; American Psychiatric 
Association, 2013). 
Embedded Measures: Embedded measures, sometimes called embedded validity indicators, allow 
examiners to assess symptom validity based upon information obtained from subtests already 
administered throughout the course of a standard neuropsychological evaluation.  Embedded measures 
are often based upon subtests that appear to be sensitive to brain injury; however, the subtests are 
relatively resistant to brain dysfunction and can therefore be used to assess symptom validity (Novitski, 
Steele, Karantzoulis, & Randolph, 2012). 
External Incentive: In the context of neuropsychological evaluation, an examinee may choose to 
malinger to obtain medications, receive financial compensation, avoid criminal sentences, evade 
military duties, or benefit in some other way.  These reasons for malingering are often referred to as 
external incentives (McDermott, Leamon, Feldman, & Scott, 2009).   
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Factitious Disorder:  Individuals with factitious disorder are characterized by intentionally fabricating 
or feigning symptoms solely for the purposes of being identified as ill or as a patient (McDermott, 
Leamon, Feldman, & Scott, 2009).   
False Negative:  A false negative or a false negative error in the context of symptom validity testing, is 
an error that occurs when a bona fide malingering examinee is not detected (Faust & Ziskin, 2011). 
False Positive:  A false positive or a false positive error in the context of symptom validity testing, is 
an error that occurs when an examinee gives full effort yet is inaccurately classified as a malingerer 
(Faust & Ziskin, 2011). 
Fixed Test Battery: Neuropsychologists who employ a fixed test battery administer the same tests to 
all examinees regardless of the referral question or other circumstances.  Using a fixed test battery has 
the advantage of allowing examiners to compare the performance of an examinee to the performance of 
a large number of people who have taken the same tests (Holtz, 2011). 
Flexible Test Battery: Neuropsychologists who employ a flexible test battery administer tests based 
upon the examinee’s referral questions or unique needs.  The advantage of using a flexible test battery 
is that by tailoring test batteries to the examinee, time usage and expense can be minimized and 
additional tests can be administered to explore areas of interest (Holtz, 2011).   
Forced Choice Test: A forced choice test presents examinees with two response choices (or another 
limited number of choices) in which only one item is correct.  In the context of assessing symptom 
validity, it may be of particular interest if an examinee scores below chance or exhibits other signs of 
reduced symptom validity (Frederick & Speed, 2007). 
Functional Magnetic Resonance Imaging (fMRI): Functional magnetic resonance imaging (fMRI) is 
a type of imaging that can provide three-dimensional images of brain and show changes in blood flow 
that tend to be correlated with mental functioning (functional magnetic resonance imaging; The 
American Heritage Medical Dictionary, 2007). 
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Intelligence: Intelligence is a psychological construct with definitions varying based upon schools of 
thought.  Many definitions of intelligence resemble a definition set forth by David Wechsler.  Wechsler 
defined intelligence as “a global capacity to interact with one’s environment through purposeful action 
and rational thought (Clauss-Ehlers, 2008).”   
Intelligence Quotient (IQ): Originally, in the early 1900’s, an intelligence quotient was an intelligence 
test scoring mechanism that was based upon a ratio of measured mental age to chronological age.  
From the mid 1900’s onwards, an intelligence quotient was commonly computed based upon an 
individual’s performance compared to the average performance of a peer group (Clauss-Ehlers, 2008).   
Litigation: A litigation is a legal dispute or a judicial contest that is brought to a court for the purposes 
of enforcement of one’s legal rights (Lehman & Phelps, 2005).   
Malingered Neurocognitive Dysfunction (MND): Malingered Neurocognitive Dysfunction (MND) is 
a voluntary exaggeration or feigning of cognitive dysfunction for the purposes of receiving substantial 
compensation or other gain, avoiding duties, or evading responsibilities.  It can be identified based 
upon criteria set forth by Slick, Sherman, and Iverson (1999).  These criteria define response bias 
patterns that would constitute MND, symptom exaggeration or misreporting, and rule-out criteria for 
MND based upon other disorders or abnormalities that could account for the observed performance of 
the examinee (Larrabee, 2007) 
Malingering: Malingering is the practice of intentionally modifying or misrepresenting one’s behavior 
for the purposes of fabricating or feigning symptoms of a disorder or disease.  Individuals who engage 
in malingering do so for the purposes of acquiring an external incentive or avoiding an external 
punishment (Slick, Tan, Sherman, & Strauss, 2011; American Psychiatric Association, 2013).   
Mild Cognitive Impairment (MCI): Mild Cognitive Impairment (MCI) consists of deficits in 
cognitive abilities without significant impairment in activities of daily living.  MCI is often associated 
with aging populations and may sometimes be a precursor to Alzheimer’s Dementia.  Several subtypes 
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of MCI have been proposed, yet diagnostic criteria has not been universally accepted (Mariani, 
Monastero, & Mecocci, 2007). 
Mild Traumatic Brain Injury (mTBI): Mild Traumatic Brain Injury (mTBI) is a caused by a head 
injury that is significant enough to disrupt the normal functioning of the brain.  Individuals with mTBI 
have at least one of the following: a loss of consciousness of less than 30 minutes, a disruption of 
mental state at the time of injury, a focal neurological deficit, a Glasgow Coma Scale score between 13 
and 15, or an amnesia after the injury that lasts less than 24 hours (Messé, Caplain, Pélégrini-Issac, 
Blancho, Lévy, Aghakhani, & ... Lehéricy, 2013). 
Neuropsychologist: A neuropsychologist, or clinical neuropsychology, engages in assessment, 
diagnosis, and treatment of individuals with brain injury or illness.  The neuropsychologist relies on 
knowledge of the brain for the purposes of helping people with brain impairment (Holtz, 2011). 
Neuropsychology: Neuropsychology, or clinical neuropsychology, is an applied psychology specialty 
that examines the behavior of individuals with normal brain functioning and determines how brain 
structure and function differs for individuals suffering from brain injury or disease (Holtz, 2011).   
Sensitivity: Sensitivity of measures designed to measure symptom validity or response bias is related 
to how effectively the measure detects malingerers.  Measures with high sensitivity tend to have a low 
false negative rate (Faust & Ziskin, 2011). 
Simulator: In the context of the malingering literature, simulators are typically healthy nonclinical 
research participants who are asked to feign deficits related to head injuries or psychopathology.  It is 
often assumed that the performance of simulators, like the performance of bona fide malingerers, will 
be lower or in some way different from individuals with legitimate head injuries or illness (Ju & 
Varney, 2000). 
Specificity: Specificity of measures designed to measure symptom validity or response bias is related 
to how effectively the measure correctly categorizes individuals giving full effort as being non-
  
SYMPTOM VALIDITY AND MEMORY 
 
20 
 
malingerers.  Measures with high specificity tend to have a low false positive rate (Faust & Ziskin, 
2011). 
Structured Interview: Structured interviews are generally created to reduce missed or inaccurate 
diagnoses by standardizing the questions asked during an interview, properly sequencing these 
questions, and quantifying responses (Rogers, 2001).   
Symptom Validity Test (SVT): SVTs are measures that are designed to provide objective information 
regarding the level of effort that a patient is giving during testing.  SVTs are generally designed to be 
insensitive to genuine cognitive or neurological deficits (Powell, Gfeller, Hendricks, & Sharland, 
2004).  SVT can take the form of either measures embedded into standard neuropsychological tests or 
free-standing tests (Henry, Heilbronner, Mittenberg, Enders, Stevens, & Dux, 2011). 
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Chapter II 
 
 
Review of the Literature 
Although numerous definitions of the word “malingering” can be found in the literature, many 
of the definitions have components in common.  Definitions tend to suggest that individuals who 
malinger, in contrast to individuals experiencing some other conditions of clinical attention, are 
intentionally modifying or misrepresenting their behavior or capabilities in certain environments or 
contexts.  Definitions, such as those provided by Slick, Tan, Sherman, & Strauss (2011), the authors of 
the Diagnostic and Statistical Manual of Mental Disorders – 4th Edition Text Revision (DSM-IV-
TR;American Psychiatric Association, 2000),  and the authors of the Diagnostic and Statistical Manual 
of Mental Disorders – 5th Edition (DSM-5; American Psychiatric Association, 2013) also tend to 
suggest that individuals who engage in malingering attempt to fabricate or feign symptoms of a 
disorder or disease.  Finally, many of the definitions of “malingering” propose that individuals who 
engage in malingering are doing so for the purposes of acquiring an external incentive or avoiding an 
external punishment (e.g. Slick et al., 2011; American Psychiatric Association, 2013).   
Behaviors that constitute malingering have been present for a long time.  According to Wessely 
(2003), malingering has existed in some form for as long as humans have gathered together into 
societies with responsibilities for individual members.  For example, malingering in the military has 
been documented since at least the Trojan War (Palmer, 2003).  The early roots of the word 
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“malingering,” have been said to have originated with the military in unknown ancient history; the 
actual word, “malingering” originated from the French (Palmer, 2003).  The first known use of the 
French word “malinger” was in 1820 (malinger; Merriam-Webster.com n.d). 
In the context of medical evaluations, malingering has likely been present for as long as this 
behavior had incentive.  Malingering in medical evaluations appeared to become more common as 
industrialized countries introduced laws that would provide support for those who could not work.  
Under Imperial Chancellor Bismarck of Germany, the 1883 Sickness Insurance Act, the 1884 Accident 
Insurance Law, and the 1889 Old Age and Disability Insurance Acts were instated (Wessely, 2003).  
During these years, the incentives for malingering increased.  In Great Britain, the Workmen’s 
Compensation Act of 1908 and the Lloyd George National Insurance Act of 1911 provided similar 
incentives to feign illness or injury (Wessely, 2003).  Interestingly, it seems to have taken decades for 
more universal, agreed-upon definitions to appear although there are still some differences in the use of 
the term.  In psychiatry, medicine, and related fields, more formal definitions of malingering appeared 
in the middle of the 20
th
 century.  The sixth edition of International Classification of Diseases (ICD-6, 
World Health Organization, 1948) provided a code specifically for “malingering” whereas a code for 
malingering was not available in earlier versions.  According to Carone and Bush (2013), in the 
Diagnostic and Statistical Manual of Mental Disorders (DSM; American Psychiatric Association, 
1952) malingering appeared as a term in the index with no set criteria.  The Diagnostic and Statistical 
Manual of Mental Disorders – 2nd Edition (DSM-II; American Psychiatric Association, 1968), defined 
malingering as being a “conscious behavior” that must be differentiated from “hysterical neurosis, 
conversion type” (Carone & Bush, 2013, p. 8).  The Diagnostic and Statistical Manual of Mental 
Disorders – 3rd Edition (DSM-III; American Psychiatric Association, 1980), provided a definition for 
malingering that read: 
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The essential feature is the voluntary production and presentation of false or grossly 
exaggerated physical or psychological symptoms.  The symptoms are produced in 
pursuit of a goal that is obviously recognizable with an understanding of the individual’s 
circumstances rather than of his or her individual psychology (p. 331). 
The DSM-III provided examples of reasons for why someone might malinger, such as avoiding 
military duty, and noted that malingering must be differentiated from conversion disorders and 
factitious disorders.  The DSM-III also acknowledged that malingering can be adaptive in situations 
such as when one has been captured by the enemy during wartime.  The Diagnostic and Statistical 
Manual of Mental Disorders- 3
rd
 Edition Revised (DSM-III-R; American Psychiatric Association, 
1987) retained an explanation of malingering that was nearly identical to the DSM-III, but the wording  
“voluntary production and presentation” was changed to “intentional production and presentation” and 
also the words “external incentive” replaced the word “goal” (p. 360).  The Diagnostic and Statistical 
Manual of Mental Disorders- 4th Edition (DSM-IV ;American Psychiatric Association, 1994) featured 
a definition of malingering that was nearly identical to the definition in the DSM-III-R, but with the 
Diagnostic and Statistical Manual of Mental Disorders – 4th Edition Text Revision (DSM-IV-TR; 
American Psychiatric Association, 2000) the words “intentional production” was changed to 
“deliberate fabrication” (p.739).  The wording of the definition of malingering in the DSM-IV-TR has 
very likely influenced other definitions that have appeared in the literature in more recent years.  
Current researchers in the field, such as Slick, Tan, Sherman, & Strauss (2011), have set forth similar 
definitions for the construct of malingering: 
The exaggeration and/or fabrication of deficits in malingering is a volitional behavior directed 
toward a substantial external incentive, either the acquisition of something desired or the 
escape from an undesirable duty, obligation, or punishment (p. 460). 
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As noted by Bush, Ruff, Trӧster, Barth, Koffler, Pliskin, Reynolds, and Silver (2005) 
neuropsychologists are particularly concerned with the idea of malingering as they must be able to 
confidently determine the validity of their findings during evaluation and attribute their data to bona 
fide examinee impairment or reduced effort.  A National Academy of Neuropsychology (NAN) 
position paper published in 2005 by Bush and colleagues defined malingering in a way that resembled 
the definitions of malingering present in the editions of the Diagnostic and Statistical Manual of 
Mental Disorders published prior to the Diagnostic and Statistical Manual of Mental Disorders – 4th 
Edition Text Revision (DSM-IV-TR; American Psychiatric Association, 2000).   The NAN definition 
from 2005 retained the “intentional production” wording found in earlier versions of the Diagnostic 
and Statistical Manual of Mental Disorders while making the rest of the definition consistent with the 
definition found in the DSM-IV-TR (Bush et al., 2005, p. 420).  The similarity of the definition 
provided in the NAN position paper with that provided in the DSM-IV-TR (American Psychiatric 
Association, 2000) suggests that the field of neuropsychology is largely in agreement with fields such 
as psychiatry on the definition of malingering.   
There appears to be a general consensus that malingering is not a disease; however, there is 
debate over whether or not malingering should be considered a mental disorder. The designation of 
malingering set forth in the DSM-IV-TR (American Psychiatric Association, 2000) as well as the 
general consensus of important figures in malingering research agree that malingering is not a 
pathological or disease process (Heilbronner, Sweet, Morgan, Larrabee, & Millis, 2009).  While the 
Diagnostic and Statistical Manual of Mental Disorders – 5th Edition  (DSM-5 ; American Psychiatric 
Association, 2013) notes that malingering is not a mental disorder, other experts in the field have 
argued or explored the possibility of malingering being a mental disorder.  Historically, there have been 
a number of viewpoints on whether or not malingering was a mental disorder.  During the World War 
II era, the popular viewpoint on malingering was that only ill people would attempt malingering 
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(Halligan, Bass, & Oakley, 2003).  Raine (2003) compared criminal behavior, malingering, and 
conditions listed in the DSM-IV against a number of criteria that could be used to define a mental 
disorder and concluded that malingering fit the criteria of mental disorder better than some other 
conditions listed in the DSM-IV.  It could be argued that malingering could be more representative of a 
mental disorder than conditions such as caffeine intoxication and schizotypal personality disorder due 
to higher treatment-seeking behavior and higher deviation from social norms (Raine, 2003, p.102).  The 
lack of agreement on whether or not malingering is a mental disorder suggests that definitions of 
malingering which assert a mental disorder status for this condition may be problematic more than 
other definitions.  Furthermore, this ongoing debate reveals that more research and explorations of the 
constructs of malingering and mental disorders is needed. 
Malingering shares a number of features with other conditions or disorders.  With this in mind, 
there may be advantages and disadvantages to discussing malingering alongside similar conditions.  
The DSM-5 departs from the previous versions of the manual by seemingly deemphasizing malingering 
as being a unique construct due to its similarities to factitious disorder.  The DSM-5 discusses 
malingering and factitious disorder under a single heading within a broader discussion of conversion 
disorder.  The DSM-5 indicates that assessment of conscious intention is unreliable and is not 
necessary for the diagnosis of a conversion disorder; however, clear signs of feigning would warrant a 
diagnosis of factitious disorder or malingering depending upon whether an individual wanted to assume 
a sick role or wanted to gain a significant incentive.  Discussing malingering alongside factitious 
disorder in the DSM-5 likely reflects the observance of the similarities by other researchers in the field.  
Consistent with the discussion of malingering and factitious disorder in the DSM-5, Lande and 
Williams (2013) noted these can present in an almost identical way.  The notable difference between 
malingering and factitious disorder is the incentive for the disorder; rather than seeking incentives or 
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avoiding undesired situations, people with factitious disorder merely wish to be considered ill (Lande 
& Williams, 2013).   
Although there is some general agreement across disciplines as to what constitutes malingering, 
the historical differences do highlight some concerns in not having a universal definition.  Current 
definitions of malingering do not tend to set clear boundaries of what can be considered malingering 
nor do these definitions make it clear whether or not malingering is a categorical or dimensional 
construct (Raine, 2003).  For example, Raine (2003) posed a question of whether or not exaggerating a 
common cold to get a day off of work could qualify as malingering.  In some sense, this would fulfill 
the criteria of some of the currently accepted definitions of malingering as an individual who 
exaggerates sickness associated with a common cold is potentially fabricating deficits in functioning 
and is doing so for the purposes of avoiding something that this individual deems as aversive.  On the 
other hand, the magnitude of symptom exaggeration, the value of the external incentive, and the 
commonality of this behavior raises a question of whether or not identifying this behavior as 
malingering would be worthwhile from a categorical viewpoint.  A related definitional problem of 
malingering and of factitious disorder is the necessity of determining how willful or conscious 
behaviors must be to align with either condition.  Halligan, Bass, and Oakley (2003) pointed out that 
proper differentiation between factitious disorders and malingering require the possibly impossible task 
of determining the level of conscious awareness, the motivations of the examinee, and the “degree of 
consciously mediated intention” (p. 9).  
Within the construct of malingering, subtypes of malingering have been defined.  Resnick 
(1997) has defined three types of malingering: Pure malingering, partial malingering, and false 
imputation.  Pure malingering is when an examinee attempts to completely fabricate symptoms of a 
specific psychiatric or neuropsychological condition.  In partial malingering, an examinee may have a 
limited set or intensity of symptoms, yet that examinee attempts to exaggerate those symptoms.  Some 
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individuals may indeed have genuine neuropsychological deficits, but may exaggerate the problem for 
personal gain (Iverson, 2003).  Examinees engaging in false imputation misattribute their current 
symptoms to another event.  For example, an examinee who has a lengthy history of memory or 
attention problems may claim that these problems were related to a recent car accident.  Although 
current nosology (e.g. DSM-5) does not tend to require greater specificity when identifying 
“malingering”, more specific terms are available for clinicians and researchers to utilize.  In many 
situations, defining specific subtypes of malingering may be unnecessary, but using terms that are less 
precise, vague, or not validated could pose problems.  Although other words could potentially be used 
in lieu of “malingering”, it may be problematic to deviate from this word in some cases.  Rogers and 
Neumann (2003) caution against using the term “secondary gain” in place of “malingering” as the 
authors state that the construct of “secondary gain” does not have empirical backing.   
Malingering As a Problem in Assessment 
Feigning and exaggerating medical and psychiatric problems have a very long history, but it has 
only been within the past two decades that increased scholarly attention has been devoted to 
understanding this phenomenon (Carone & Bush, 2013).  For decades, neuropsychologists have 
realized that it is necessary to use objective measures to supplement clinical judgment in some cases.  
In 1978, an article, “Prospects for faking believable deficits on neuropsychological testing”, 
specifically addressed the topic of malingering and the need to assess symptom validity in objective 
ways (Heaton, Smith, Lehman, & Vogt, 1978).  During this study, participants with verified head 
injuries (n = 16) and participants who were simulating malingering (n = 16) were administered a 
battery of neuropsychological tests.  In this study, the Wechsler Adult Intelligence Scale (WAIS; 
Wechsler, 1955), the Minnesota Multiphasic Personality Inventory (MMPI; Hathaway & McKinley, 
1942) and the Halstead-Reitan Neuropsychological Battery (HRNB; Reitan & Wolfson, 1993) were 
administered by an experienced technician.  This technician was “blinded” by being completely 
  
SYMPTOM VALIDITY AND MEMORY 
 
28 
 
unaware of the fact that the participants were not real patients.  This study used neuropsychologists (n 
= 10) with a range of experiences, which would likely be representative of practicing 
neuropsychologists in the field, as judges.  These neuropsychologist judges were asked to determine 
which participants were malingering by solely examining their test scores.  The neuropsychologist 
judges were able to correctly classify between 50% and 68% of participants.  With neuropsychologist 
judges having identification accuracy that was barely better than chance, this study strongly suggested 
that examination of test scores of common measures alone is not sufficient for the identification of 
malingerers.  Heaton and colleagues (1978) did, however, note that these neuropsychologist judges 
may have had limited experience with malingerers and that these judges were deprived the chance to 
directly observe patients or know the observations of the technicians.  So, the accuracy rates could have 
improved if the neuropsychologists had access to data that they would often be able to obtain in routine 
practice.     
 Avoiding over and under-identifying malingering is crucial and often a key component of the 
assessment process. For example, to illustrate the high-stakes nature of this process,  it is possible that 
misclassifying individuals could result in acquitting a defendant by reason of insanity, altering the 
severity of a sentence, finding an individual incompetent to stand trial, or impeding necessary treatment 
(Toomey, Kucharski, & Duncan, 2009).  Interestingly, despite the very high stakes associated with 
misclassification of malingering, the American Psychological Association has not made specific ethical 
principles regarding malingering in the Ethical Principles of Psychologists and Code of Conduct; 
however, in standard 9.01, it generally addresses malingering by noting: 
 Psychologists base opinions contained in their recommendations, reports and diagnostic  
or evaluative statements, including forensic testimony, on information and techniques 
sufficient to substantiate their findings (American Psychological Association, 2010, 
para. 1). 
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Methods of Malingering Assessment 
With the high-stakes nature of many neuropsychological evaluations in mind, it is crucial for 
neuropsychologists to adopt measures and methods that elucidate which patients are giving genuine 
effort.  There are presently a number of methods of detecting malingering available to 
neuropsychologists.  Practitioners can attempt to detect malingering through clinical intuition which 
could be informed by observations of the examinee and review of the examinee’s history.  Practitioners 
can also use specialized measures, such as symptom validity tests to directly address the possibility of 
malingering during the course of an examination.  Practitioners can also examine performance on 
commonly used neuropsychological assessment measures and use formulas to determine likelihood of 
patterns of performance.  Regardless of the methods chosen to detect malingering, there are two 
general strategies used for the detection of malingering: finding examinees to be excessively impaired 
and finding examinees to exhibit unexpected performance patterns (Rogers & Bender, 2003).   
Some guidelines have been proposed for how neuropsychologists should attempt to examine the 
possibility of malingering.  To detect malingering, Iverson (2003) recommends that practitioners use 
specialized symptom validity tests as well as examine the performance patterns on common 
neuropsychological tests that are administered for the purposes of assessing other areas of functioning.  
It is also recommended that clinicians intersperse validity indicators throughout the evaluation 
(Iverson, 2003).  Neuropsychologists who opt to only examine validity indicators during certain 
portions of an evaluation risk not detecting possible fluctuating effort given by examinees.  Heilbronner 
and colleagues (2009) also offered a set of guidelines for evaluating neuropsychological response 
validity and communicating those findings.  Among these guidelines, it was noted that 
neuropsychologists use psychometric indicators to ensure validity, use stand-alone and embedded 
validity indicators, compare test data with known “real-world” performance, compare obtained data 
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with documented disorders, intersperse validity indicators throughout the assessment, and use serial 
evaluations when possible.   
Using measures beyond clinical intuition can be crucial regardless of setting and incentive.  
Pella and colleagues (2012) using a sample of self-referred students from a Southern university 
psychological clinic (n = 986) and a control student sample (n = 182) concluded that university 
students who exaggerate symptoms may obtain their desired outcomes when symptom validity 
indicators such as empirically supported embedded validity indicators are not used.  In this study, some 
self-referred students from the study with Pella and colleagues (2012) had known external incentives 
while others had no known external incentives.  Although flexible test batteries were used, all of the 
examinees had Wechsler Adult Intelligence Scale – Third Edition (WAIS-III; Wechsler, 1997a) and 
Wechsler Memory Scale – Third Edition (WMS-III; Wechsler, 1997) data and some examinees had 
Personality Assessment Inventory (PAI; Morey, 1991) data.  Symptom validity in this study was 
assessed via embedded measures on the measures of memory and cognitive functioning.  Pella and 
colleagues (2012) noted that failure of embedded measures was high for students with and without 
external incentive, but found the expected patterns of students with external incentive having poorer 
neuropsychological performance and higher rates of failing embedded measures.  Undoubtedly, 
individuals in a college setting as well as many other settings may be capable of malingering and 
remaining undetected if symptom validity indicators are not used.   
Unfortunately, several surveys have demonstrated that symptom validity tests are sometimes 
not used even in settings where malingering would be likely.  Slick, Tan, Strauss, and Hultsch (2004) 
found that the majority (79%) of neuropsychologists who handle financial compensation claim or 
personal injury litigation use a symptom validity test; however, this figure demonstrates that a sizable 
minority of neuropsychologists in this environment do not employ these tests.  More recently Sharland 
and Gfeller (2007), using a survey from a sample of NAN professional members (n = 712), found that a 
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little more than half of the members frequently utilized measures of symptom validity within their 
evaluations.  Sharland and Gfeller (2007) also found that there was inconsistency regarding whether or 
not practitioners warned their patients about the possibility of symptom validity tests being used; 52% 
rarely or never give a warning while 27% often or always provide a warning.  It also appears that 
practitioners have their own preferences regarding measures and therefore employ a wide variety of 
measures.  Sharland and Gfeller (2007) found that the five most popular symptom validity or response 
bias tests were the Test of Memory Malingering (TOMM; Tombaugh, 1996), two scales from the 
Minnesota Multiphasic Personality Inventory, Second Edition (MMPI-2; Butcher et al., 2001), the Rey 
15-Item test (Rey-15; Rey, 1964), and the California Verbal Learning Test (CVLT; Delis, Kramer, 
Kaplan, & Ober, 1987).   
Lezak, Howieson, and Loring (2004) noted that people who attempt to malinger often claim to 
have impaired memory.  With impaired memory being a common complaint for malingerers, it has 
been recommended that clinicians consider using malingering or symptom validity tests that appear to 
measure memory (Lezak et al., 2004).  Lezak and colleagues (2004) have also recommended that 
clinicians look for patterns in existing memory measures. 
Unfortunately, attempting to assess symptom validity in one area of functioning does not 
always result in an accurate assessment of symptom validity in another area.  Haggerty, Frazier, Busch 
and Naugle (2007) investigated how well separate measures of cognitive symptom exaggeration relate 
to each other and well as how these cognitive symptom exaggeration measures relate to 
psychopathological symptom exaggeration.  To address their research questions, Haggerty and 
colleagues (2007) used archival data from patients (n = 300) with neurological and neurodegenerative 
disorders referred for neuropsychological evaluation for assessment of functioning.  Patients in the 
sample used for this study appeared to match the expected demographic of patients at a Midwestern 
hospital.  About 16% of the sample was seeking compensation for their condition or were involved in 
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litigation.  All selected patients completed the VSVT and PAI in a manner consistent with standard 
administration and interpretation.  The performance of the patients was classified as valid or invalid 
based upon scores obtained on the VSVT.  Haggerty and colleagues (2007) found moderate correlations 
between VSVT accuracy and latency scores (r = -.37 to -.64).  Modest correlations of less than r = .17 
were found amongst the VSVT accuracy and latency scores and the PAI Negative Impression 
Management validity scales; however, no significant correlations with the other PAI validity scales 
were found.  This study, although exploratory in nature, suggests that validity scales within a measure 
may have notable relationships; however, validity scales across measures which assess different 
constructs may tend to have weaker relationships.  On a practical level, this also advocates for the use 
of symptom validity measures for multiple areas of functioning during the course of an evaluation.   
Assessing Malingering With Observational Techniques 
 Practitioners and researchers can sometimes detect malingering via careful observation and 
review of an examinee’s history.  Bush and colleagues (2005) indicated that malingering may be 
present if an examinee’s self-reported history differs from documented history, the self-reported 
symptoms are inconsistent with known patterns of brain functioning, the self-reported symptoms are 
inconsistent with patterns on administered psychological tests, self-reported symptoms are inconsistent 
with behavioral observations, or the self-reported symptoms conflict with information gathered from 
other informants.   
 Aside from inconsistent historical information and questionable psychological test performance, 
sometimes neuropsychologists or other practitioners can detect malingering through physical 
examination.  Descriptions of physical examination techniques for the detection of malingering have 
existed for decades.  Waddell, McCulloch, Kummel, and Venner (1980) released a noteworthy 
publication that detailed some of the techniques available for differentiating between pain with physical 
correlates and “nonorganic physical signs.”  Waddell and colleagues (1980) wrote that finding three or 
  
SYMPTOM VALIDITY AND MEMORY 
 
33 
 
more categories of the five listed categories of physical signs is clinically significant.  The five 
categories given were related to tenderness inconsistent with known neuroanatomy, back pain reported 
with certain loading and rotation tasks that should not produce back pain, differing abilities to move 
while being distracted, disturbances present over regions of the body that would be inconsistent with 
known neuroanatomy, or overreactions to physical tests.  These “nonorganic physical signs”, 
sometimes called “Waddell signs”, may be helpful in identifying malingering; however, some 
researchers such as Fishbain, Cutler, Rosomoff, and Rosomoff (2004) have found little or no 
association between Waddell signs and four other methods of identifying malingering.  Specifically, 
Fishbain and colleagues (2004) reviewed the findings and the scientific quality of 16 studies related to 
Waddell signs and found that 75% of the reports found no association between Waddell signs and 4 
other methods of identifying malingering patients.  This research is a reiteration of the common 
recommendation present in the literature: Multiple methods should be used when assessing the 
possibility of malingering. 
Other physical examination techniques aside from those defined by Waddell and colleagues 
(1980) have been defined.  Greer, Chambliss, and Mackler (2005) provided explanations of some other 
physical examination techniques for detecting malingering.  Greer and colleagues (2005) made 
reference to a number of tests available for the detection of malingering.  These tests included 
“McBride’s Test, Mankopf’s Test, Waddell’s Test, Hoover’s Test, the Abductor Test, the Arm Drop 
Test, and the Midline Split Test” (p.720).  Greer and colleagues (2005) noted that the listed physical 
examination techniques tended to have few or no published studies examining the efficacy of the 
techniques and noted that “no examination technique objectively proves malingering” (p. 719). 
Assessing Malingering With Embedded Validity Indicators 
Some researchers and practitioners have attempted to look at patterns in common 
neuropsychological and psychological measures for the purposes of developing objective ways to 
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detect malingering.  The advantage of examining these embedded validity indicators is that this 
information is often available in routine neuropsychological examinations (Novitski, Steele, 
Karantzoulis, & Randolph, 2012).  In general, adopters of this method reason that the more unusual the 
results are on various assessments, the more likely it is that malingering is present.  
Embedded validity indicators are available for a number of assessments used during 
neuropsychological evaluations.  Trueblood and Schmidt (1993) assembled cut scores for some 
Halstead-Reitan Neuropsychological Battery (HRNB; Reitan & Wolfson, 2004) tests (e.g. Seashore 
Rhythm Test) and other measures (e.g. finger agnosia errors) and found that with 3 cut scores reached, 
approximately 14% of the cases were false positives.  This indicates that while using cut scores for 
common neuropsychological tests for the purposes of identifying malingering, malingerers will often 
be identified; however, a sizable minority of people giving genuine effort will be erroneously identified 
as malingerers.  Mittenberg, Rotholc, Russell, and Heilbronner’s (1996) accuracy of identifying 
malingerers using the HRNB was similar to the accuracy found in Trueblood and Schmidt’s (1993) 
study.  Mittenberg and colleagues (1996) were able to use HRNB performance to correctly identify 
88.75% of the groups with 93.8% true negatives and 83.8% true positives.  Mittenberg and colleagues 
(1996) reached these conclusions by administering the HRNB to normal volunteers who were instructed 
to simulate malingering (n = 40) and nonlitigating head trauma patients (n = 40).  By analyzing the test 
results via MANOVA, Mittenberg and colleagues (1996) found that the simulated malingerers 
generally performed worse than head trauma patients on tests measuring sensory, motor, and 
attentional performance; head injury patients tended to perform worse on more complicated cognitive 
measures such as the Tactual Performance Test and the Trails B test.   
Silverberg, Wertheimer, and Fichtenberg (2007) developed an embedded measure, known as 
the Effort Index (EI), for the Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS; Randolph, 1998) which reportedly had “good discriminability” when differentiating between 
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groups with cognitive dysfunction and groups with poor effort (p. 841).  Novitski and colleagues 
(2012) developed an effort scale (ES) for the RBANS and found that it was able to discriminate between 
people with amnestic disorders and poor effort markedly better than the EI developed by Silverberg 
and colleagues (2007).  Novitski and colleagues (2012) developed their ES scale by using existing 
RBANS data obtained from patients with mild traumatic brain injuries (mTBIs; n = 25), patients with 
amnestic mild cognitive impairment (MCI; n = 15) and patients with probable Alzheimer’s disease (n = 
54) who had no known somatoform tendencies or incentives to alter performance for secondary gain.  
Novitski and colleagues (2012) compared their obtained data to the normal population in the RBANS 
standardization sample (n = 540).  Novitski and colleagues (2012) found that only 17% of people in the 
standardization group scored below a specific cut score on a composite formed by summing digit span 
and list recognition scores whereas 78% of the impaired sample in the study scored below this cutting 
score.  Novitski and colleagues (2012) concluded that examinees with scores under this level should be 
regarded as likely either being impaired or giving reduced effort during testing.  Although embedded 
measures such as the ES on the RBANS  lack specificity and sensitivity compared to some standalone 
measures, the authors pointed out the utility of this embedded measure as it was developed using 
information that can be automatically collected during the course of a brief neuropsychological 
evaluation.   
Constantinou and colleagues (2005) found that some subtests of the commonly used Wechsler 
Adult Intelligence Scale – Revised (WAIS-R; Wechsler, 1981) were sensitive to malingering.  Williams 
(2011), like Constantinou and colleagues (2005), found that certain subtests on the WAIS-R were more 
or less sensitive to malingering.  Specifically, it was found that Digit Span, Arithmetic, and all of the 
Performance subtests were impacted more than the verbal subtests when examinees malingered.  For 
the Williams (2011) study, determination of malingering, for the purposes of measuring WAIS-R 
subtest sensitivity was determined by results on the Test of Memory Malingering (TOMM; Tombaugh, 
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1996). A part of the WAIS-R that is particularly useful for detecting malingering is Digit Span and an 
extrapolated scale, Reliable Digit Span (RDS); malingering classification accuracy for Digit Span has 
been established (Heinly, Greve, Bianchini, Love, & Brennan, 2005).  Miele, Gunner, Lynch, and 
McCaffrey (2012) found RDS to be superior to all of the other tested embedded validity indicators.   
Miele and colleagues (2012) reached these conclusions by conducting an analysis of archival data from 
examinees (n = 50) who were examined by a neuropsychologist for medico-legal purposes and who 
mostly had claims related to mTBIs.  The examinees took the Rey 15 (Rey, 1964), the  TOMM 
(Tombaugh, 1996), the Victoria Symptom Validity Test (VSVT; Slick, Hopp, Strauss, & Thompson, 
1997), and the Word Memory Test (WMT; Green, 2003).  The examinees also provided validity data 
through embedded measures on the WAIS-R (Wechsler, 1981) and the Halstead-Reitan 
Neuropsychological Battery (HRNB; Reitan & Wolfson, 1993).  Miele and colleagues (2012) used cut 
scores from the standalone symptom validity tests that were specified in the manual and used cut scores 
for the embedded measures present in the literature.  Miele and colleagues (2012) noted that some 
embedded measures were tested with multiple cut scores mentioned in the literature.  A total of 17 
possible embedded validity scores were analyzed.  Miele and colleagues (2012) utilized a logistic 
regression to determine the ability of the embedded validity indicators to predict group membership for 
people failing or not failing standalone symptom validity indicators.  It was found that only four of the 
embedded validity indicators could significantly group examinees based upon symptom validity.  The 
four embedded validity indicators that were successful at grouping examinees were Reliable Digit 
Span, Category Test (CT) Total Errors on subtest 7, Speech Sounds Errors, and Tactile Finger 
Recognition Total Errors.  Miele and colleagues (2012) found that of all embedded validity indicators, 
RDS proved to be the most useful.  RDS with a proper cut score could correctly classify 74% of 
examinees; however, it was noted that there was a false-positive rate of nearly 20% with RDS.  In 
addition to detecting malingering, Digit Span and Reliable Digit Span performance can serve as 
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indicators of suboptimal effort for individuals with Attention Deficit-Hyperactivity Disorder and 
individuals with Learning Disorders (Harrison, Rosenblum, & Currie, 2010). 
Binder, Villanueva, Howieson, and Moore (1993) found that the profile of performance on the 
Rey Auditory Verbal Learning Test (RAVLT; Lezak, 1983) could be noticeably altered when examinees 
engaged in malingering.  Binder and colleagues (1993) suggested examinees scoring below a certain 
score on the RAVLT recognition task should be carefully assessed for malingering; however, poor 
recognition scores are not pathognomonic of malingering.  Conditions such as Alzheimer’s dementia, 
aphasia, and alexia could also cause poor RAVLT recognition scores (Binder et al., 1993).  Green, 
Rohling, Lees-Haley, and Allen (2001) also similarly found that the level of severity of neurological 
illness or head injury does relate to scores obtained on symptom validity tests. 
Armistead-Jehle and Buican (2013) designed a study for investigating the efficacy of the 
Advanced Clinical Solutions package (ACS; Pearson, 2009) in comparison to the stand-alone Word 
Memory Test (WMT; Green, 2003) for the measurement of symptom validity.  The ACS relies upon 
information obtained from assessment with the Wechsler Memory Scale, Fourth Edition (WMS-IV; 
Wechsler, 2009) and the Wechsler Adult Intelligence Scales-Fourth Edition (WAIS-IV; Wechsler, 
2008).  Using embedded measures and additional subtests (e.g. Word Choice Test), the ACS provides 
information and norms that can allow for users to obtain estimates of pre-morbid intelligence, 
executive function, social perception, and symptom validity.  Armistead-Jehle and Buican’s (2013) 
study utilized data from U.S. military members (n=280) with mild TBI.  The authors noted that the 
WMT and all parts of the neuropsychological battery were administered using standard instructions 
aside from the examiner remaining in the room while the WMT was administered.  Armistead-Jehle and 
Buican (2013) compared performance for the ACS and WMT at various base rate levels and found that 
the ACS had high specificity but low sensitivity.  The authors found that at the 10% base rate level for 
the ACS, there were 32% of cases where the WMT was failed, but the ACS was passed and only 0.4% 
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of cases where the ACS was failed but the WMT were passed.  The authors found that 62% of people 
passed both the WMT and ACS and just 6% of people failed both measures.  The authors found that 
similar trends were present at other ACS base rates, but concluded that better specificity and sensitivity 
could be achieved at base rates higher than recommended by ACS documentation.  Armistead-Jehle 
and Buican (2013) also concluded that embedded measures, such as the ACS can provide useful 
information, but that other methods for detecting malingering, such as using stand-alone symptom 
validity tests should also be employed.     
Accuracy of embedded validity indicators can be improved by examining multiple measures.  
For example, using the WAIS-R Digit Span (Wechsler, 1981) scaled score, Knox Cube Test (Stone & 
Wright, 1980) total score, and Recognition Memory Test (Warrington, 1984), Iverson and Franzen 
(1994) established a 98% classification accuracy for malingerers and non-malingers based upon 
performance of 100 university students, federal inmates, and patients.  Meyer and Volbrecht (2003) 
found that by using cutoff scores on a battery of nine common neuropsychological measures (e.g. 
WAIS-R, Wechsler, 1981; Trail Making Test, Reitan & Wolfson, 1985); Animal Naming (Strauss, 
Sherman, & Spreen, 2006), it was possible to classify over 700 examinees correctly with a 0% false 
positive rate and a 17% false negative rate.  This level of accuracy could be obtained by considering 
people as malingering if they exceeded two cutoff scores (Meyer & Volbrecht, 2003). 
Although methods such as examining built-in validity indicators in existing measures for 
malingering yield useful information, there is a consensus among experts suggesting information 
beyond that obtained with embedded validity indicators should be used for a determination of examinee 
symptom validity.  Lezak, Howieson, and Loring (2004) noted positive findings with embedded 
measures suggest that a problem is likely present, but negative findings do not rule out the possibility 
of a problem.   Heilbronner and colleagues (2009) recommended that practitioners employee both 
stand-alone symptom validity measures and embedded validity indicators when assessing malingering.  
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Whitney (2013, p. 233) wrote that “embedded symptom validity measures are best not used in 
isolation.”  Practitioners, therefore, should augment this information with other method of detecting 
poor effort.   
 
Using Dedicated Symptom Validity Testing for Detecting Malingering 
Practitioners can elect to utilize tests specifically designed to assess effort and symptom 
validity.  Although symptoms validity tests can take a variety of forms, a common format is the 
“forced-choice test”.  Clinicians sometimes utilize forced-choice tests when malingering is suspected 
(Lezak et al, 2004).  These forced-choice tests work by having an examiner present items to an 
examinee and then requiring an examinee  to respond by choosing an answer from specific presented 
items.  In the interest of test security of these assessments, more specific details about these tests are 
intentionally omitted from this manuscript.   
According to Lezak and colleagues (2004), some of the most commonly used forced choice 
measures include: Forced Choice Test (Hiscock & Hiscock, 1989), Portland Digit Reconstruction Test, 
Amsterdam Short-Term Memory Test, Test of Memory Malingering (TOMM; Tombaugh, 1996), 
Validity Indicator Profile, and The Victoria Symptom Validity Test (VSVT).  The Rey 15-Item Test or 
Rey I (Rey-15; Rey, 1964) is commonly used by neuropsychologists handling financial compensation 
claims (Slick, Tan, Strauss, & Hultsch, 2004).  Slick and colleagues (2004) point out that quite 
interestingly, the Rey I is used frequently despite evidence of its inefficacy.   
Although a number of forced-choice tests are available, some tests clearly have larger bases of 
research and larger user bases.  The TOMM appears to be the most widely used and studied test of 
cognitive underperformance (Jelicic, Ceunen, Peters, & Merckelbach, 2011).  One of the attributes 
about the TOMM that likely interests researchers and clinicians is its accuracy.  Gervais, Rohling, 
Green, and Ford (2004) have found that the TOMM has less than a 1% false positive rate.  Even with 
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the high accuracy provided by the TOMM, researchers are still finding other ways to examine symptom 
validity tests, like the TOMM, in hopes of further improving its accuracy.  Gunner, Miele, Lynch, and 
McCaffrey (2012), for example, applied criteria developed for the Word Memory Test (WMT, Green, 
2003) to the TOMM and found that a newly developed Albany Consistency Index (Gunner, et al., 2012) 
provided greater sensitivity and specificity for the TOMM.  Denning (2012) also examined the TOMM 
and found that administration of just the first trial of the TOMM was more effective in identifying poor 
effort compared to administration of the entire TOMM when using the TOMM to predict results of the 
Medical Symptom Validity Test (MSVT; Green, 2004).  It was also found that by adjusting cutoff scores 
for the TOMM, based upon whether or not neurological dysfunction was suspected, accuracy of the 
TOMM could be improved further (Denning, 2012).   
The usefulness of symptom validity tests, such as the TOMM, can be partly determined by its 
ability to be usable and accurate with a wide array of people.  The accuracy of the TOMM appears to be 
very high even when working with populations with bona fide impairments although there are some 
notable exceptions.  Hill, Laurie, Kennedy, and Malamut (2003), for example, found that performance 
on the TOMM was impacted by temporal lobe dysfunction; however, performance on this measure was 
not impacted enough to be below the cutoff score for low effort or malingering.  Teichner and Wagner 
(2004) found normal and cognitively impaired elderly people could be correctly classified using the 
TOMM; however, misclassification rates for elderly individuals with dementia were high.  Rees, 
Tombaugh, and Boulay (2001) found that severe depression and affective state did not significantly 
impact examinee performance on the TOMM.  Brooks, Sherman, and Krol (2012) also found that the 
TOMM could be largely passed by children who have been considered to be low functioning. 
Although the TOMM may be a common choice for practitioners requiring symptom validity 
testing, some researchers have found that other symptom validity tests may offer superior attributes.  
Armistead-Jehle and Gervais (2011) found that the Nonverbal Medical Symptom Validity Test (NV-
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MSVT; Green, 2008) had a greater sensitivity to poor effort compared to the TOMM while maintaining 
acceptable false positive rates using the MSVT and Word Memory Test (WMT, Green, 2003) as external 
criteria.  In Armistead-Jehle and Gervais’s (2011) study, examinees in the Province of Alberta, Canada 
who were claiming disability not related to head injury (n = 345) were given the NV-MSVT and the 
TOMM among other tests in a neuropsychological battery.  Although Armistead-Jehle and Gervais 
(2011) were unable to know for sure which examinees were malingering due to the nature of their 
clinical sample, they used the MSVT and the WMT as the criteria in the study to determine whether or 
not examinees malingered.  In this study, there was a tendency for participants to pass the TOMM and 
fail the NV-MSVT.  Using the MSVT and WMT criteria, the authors made determinations of whether the 
TOMM was producing false negatives or the NV-MSVT was producing false positives. The authors 
found that the NV-MSVT was twice as sensitive as the TOMM to poor effort and maintained acceptable 
levels of specificity.   
Researchers and practitioners have good alternatives to the TOMM available. This is important 
for situations in which a second standalone symptom validity test would be indicated or in situations 
where different tasks or modalities would be more appropriate for specific examinees.  The Word 
Memory Test (WMT, Green, 2003) is a test designed to assess verbal memory, learning and symptom 
validity (Flaro, Green, & Robertson, 2007).  The WMT is regarded by some as being unique among the 
available symptom validity tests because of the number of validation studies conducted on clinical 
samples (Green, Lees-Haley, & Allen, 2003).   Hartman (2002) described the WMT as being “robust” 
and having a “large normative base” as well as being supported by ongoing research after its 
publication.  The WMT is a computerized symptom validity test that assesses an examinee’s ability to 
recognize previously presented word pairs (Green, 2003).  The WMT can also be administered via a 
paper and pencil method.  Hoskins and colleagues (2010) have found that the computerized version of 
the WMT appears to be equivalent to the orally presented version.  Although the WMT and TOMM have 
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similar goals of measuring symptom validity during an evaluation, the WMT task differs because it 
relies more upon verbal memory whereas the TOMM task generally relies upon visual memory.  The 
WMT has been advertised as a test that is almost solely sensitive to poor effort.  Flaro, Green, and 
Robertson (2007) have noted that the symptom validity components of the WMT were designed to be 
“virtually insensitive to all but the most extreme forms of impairment of learning and memory” (p. 
374).A number of studies have been conducted that investigate how sensitive the WMT is to anticipated 
factors such as poor effort or unintended factors such as genuine cognitive dysfunction, reading level, 
or age.  In one study, Green and Flaro (2003) make the case that the WMT measures symptom validity 
rather than ability by demonstrating that children from age 7 to age 18 perform similarly on this test as 
long as they possess a third grade reading level.  However, Allen, Bigler, Larsen, Goodrich-Hunsaker, 
and Hopkins (2007) found via fMRI that the WMT activates dorso-lateral prefrontal cortex, superior 
parietal lobes, and the anterior cingulate and concluded that the WMT requires “significant” cognitive 
effort.  Larsen, Allen, Bigler, Goodrich-Hunsaker, and Hopkins (2010) replicated the study of small 
group of young adult men (n = 4) by Allen et al. (2007) using a larger sample size (n = 10) which 
included an equal number of young adult men and women.  Larsen and colleagues (2010) found very 
similar patterns of brain activation in the replication study during the delayed recognition portion of the 
WMT and did not find sex differences.  In a study with three amnestic patients with known 
hippocampal brain damage and four matched controls, Goodrich-Hunsaker and Hopkins (2009) found 
that performance on each task of the WMT was approximately three standard deviations lower than the 
mean performance of adult control participants.  Interestingly, although the amnestic patients were 
clearly impaired with their WMT performance, they all still scored above the WMT cut scores and 
therefore were categorized as giving adequate effort.   
The literature suggests that symptom validity tests can be sensitive to the effects of substances.  
In a 2011 study, Loring, Marino, Drane, Parfitt, Finney, and Meador conducted a double-blind, 
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placebo-controlled, crossover study which investigated how a 2 milligram dose of lorazepam impacted 
performance on the WMT.  Loring and colleagues (2011) found that 6 of the 28 participants in the study 
failed the WMT while on lorazepam whereas they were able to pass the WMT under a placebo 
condition; 1 of the 28 participants failed the WMT under placebo condition but not while taking 
lorazepam in the experimental condition.  It was concluded that variables such as lorazepam can impact 
functioning on cognitive tests and on symptom validity tests and that this should be taken into account 
while clinicians may decisions (Loring et al., 2011). 
Some symptom validity tests may be more vulnerable to distraction.  Batt, Shores, and 
Chekaluk (2008) found that the TOMM was more resilient to distraction compared to the WMT and 
therefore may be less impacted by some forms of cognitive disability.  Batt and colleagues (2008) 
designed a study utilizing non-litigating participants with either traumatic or non-traumatic brain 
injury.  The participants were randomly assigned to Simulated Malingering (n = 11), Distraction (n = 
24), or Full Effort (n = 25) groups and were given the TOMM and WMT in counterbalanced order.  The 
individuals instructed to give full effort were given standard instructions and a standard administration 
of the TOMM and WMT.  The individuals in the distraction condition were asked to orally add 3 to a 
number presented every 3 seconds throughout the duration of the learning portions of the WMT and 
TOMM.  The individuals in the simulated malingering group were given instructions to fake a memory 
impairment without faking to a degree that it was obvious.  Batt and colleagues (2008) found that WMT 
performance was significantly impacted by distraction whereas TOMM performance was not.  
Interestingly, both tests were 100% sensitive to the simulated malingering; however, specificity for the 
TOMM under a full effort condition was 84% and for the WMT it was 56%.  The literature reveals that 
there is some argument over the superiority of symptom validity tests such as the TOMM and WMT.  
Martins and Martins (2010) described the WMT as one of the best tests for memory malingering despite 
some noted concerned about its false positive rate.  While some researchers have expressed concern 
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about the false positive rate of the WMT, other researchers have found ways to explore and address 
these concerns.  Green, Montijo, and Brockhaus (2011), while considering a “dementia profile” (p.92) 
for people with probable dementia concluded the false positive rate of the WMT was no higher than 
1.6%.  Green and colleagues (2011) formed a study with 60 participants who had probable, mild, 
moderate dementia or no impairment based upon a Clinical Dementia Rating scale (CDR; Morris, 
1993).  Participants were given the WMT with the option of having the examiner read stimulus items 
and control the computer mouse.  The authors noted that the interval between trials was also shortened 
to reduce task demands.  The examiners found that all groups of participants had differing levels of 
performance on the WMT depending upon level of impairment.  It was also found that scores on a 
simpler task, the MSVT, were higher for all groups of participants.  Using profile analysis, Green and 
colleagues (2011) were able to eliminate all cases of false positives in the dementia groups in the study.   
Greiffenstein, Greve, Bianchini, and Baker (2008) wrote that some of the research concluding 
the superiority of the TOMM is erroneous due to methodological flaws.   Green (2007) also suggested 
the WMT has properties which make it superior to the TOMM.  The agreement rate between the TOMM 
and WMT is 77.2% according to Greiffenstein and colleagues (2008).  Greiffenstein and colleagues 
(2008) tested the agreement rate by using data from 473 people who were in neuropsychological 
evaluations for the purposes of receiving compensation due to possible cognitive or persistent pain 
disability related to neurological trauma.  The TOMM and WMT were administered in each of the 
neuropsychological evaluations.  The administration and interpretation of the TOMM and WMT were 
standard aside from the cut scores from Trial 2 of the TOMM being applied to all three parts of the 
TOMM to make WMT and TOMM comparisons symmetrical.   The authors found that in 13.7% of 
cases, examinees failed the WMT and passed the TOMM; in 9.1% of cases, examinees failed the 
TOMM but passed the WMT.  Greiffenstein and colleagues (2008) concluded that especially after 
observing cut scores on all three parts of the TOMM, there is no reason to conclude that either the 
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TOMM or WMT is superior.  The agreement rate is high enough on tests like the TOMM and WMT to 
demonstrate the usefulness of symptom validity tests, but low enough to demonstrate the need for 
neuropsychologists to consider these tests in the context of other available information.  Flaro, Green, 
and Robertson (2007), using participants with incentives to perform well on testing, incentives to 
appear impaired on testing, and no significant incentives to modify performance found the expected 
patterns of performance on the WMT with those having incentive to appear impaired failing the WMT 
more frequently. 
Bauer, O’Bryant, Lynch, McCaffrey, and Fisher (2007) evaluated the efficacy of shortened 
versions of the WMT and the TOMM.  Bauer and colleagues (2007) utilized archival data from 64 
examinees who were litigants with mild traumatic brain injuries.  The authors administered the TOMM 
and WMT according to standard instructions and used the classification based upon the TOMM and 
WMT manuals as the criteria for assessing accuracy of shortened versions of the tests.  For both the 
WMT and for the TOMM, using just the WMT’s Immediate Recall or just the TOMM’s Trial 1 resulted 
in high sensitivity and specificity.  Bauer and colleagues (2007) concluded that using the shortened 
versions of the TOMM or WMT could result in useful screening measures as sensitivity and specificity 
over 0.8 were possible for either measure if correct cut scores were used.   
Test security is a concern for symptom validity tests as well as some of the other tests 
developed for neuropsychological assessment.  Examinees who have been able to study test materials 
or receive coaching prior to an evaluation may be able modify their performance in such a way that 
their results are invalid.  Unfortunately, it appears that information on symptom validity tests may be 
readily accessible to some examinees.  Bauer and McCaffrey (2006) found that enough information on 
the TOMM, VSVT, and WMT was located on the Internet to potentially threaten the validity of the tests.  
With the help of a graduate student, Bauer and McCaffrey (2006) used the search engine “Google” on 
two different occasions to examine the top 50 results on the three symptom validity tests.  The authors 
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found that over the course of four months, some of the search results had changed; the more recent 
results were used for analysis.  Depending on specificity of test descriptions on the websites, four 
different threat levels were assigned.  Although Bauer and McCaffrey (2006) concluded that the 
TOMM search results had the highest number of “high” threat level websites, they gave examples of 
some specific alarming findings such as a readily accessible sample psychological report with VSVT 
score ranges and classifications.  On the TOMM, VSVT, and WMT, various information on cut-off 
scores, recording of reaction times, and item difficulty was readily accessible on the Internet (Bauer & 
McCaffrey, 2006). 
The possibility of disclosure of sensitive test information may in some cases be unintentional.  
Psychologists, attorneys, and laypeople may have some access or familiarity with test information and 
be unaware of the problems associated with disclosing this information.  Morel (2009) posits that 
applied neuropsychology has not issued guidelines to attorneys regarding test information that can and 
cannot be shared with clients and therefore the attorneys sometimes disclose information without 
knowledge of how it can impact the validity of neuropsychological examinations.  It is likely that many 
legal professionals would be receptive to receiving information on test security of psychological 
measures as evidenced by statements made by U.S. Supreme Court justices since at least the late 
1970’s (Morel, 2009).  Morel (2009) provided comprehensive guidelines for how attorneys can 
appropriately prepare a client without threatening validity of neuropsychological evaluation results.  
Prior to neuropsychological evaluation, there is a potential that examinees may be warned of the 
presence of symptom validity indicators or even coached on how to perform on certain tests.  Although 
coaching may cause examinees to modify their behaviors and responses during a neuropsychological 
evaluation, some symptom validity tests have been shown to be resilient to coaching.  Davis, Wall, & 
Whitney (2012) noted differences in performance on the WMT and TOMM for simulated naïve and 
simulated coached malingering groups; a second clinical validation study using data from actual VA 
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hospital neuropsychological examinations was also conducted.  Davis and colleagues (2012) developed 
three consistency scales for the TOMM that measured if examinees were consistently correct or 
incorrect with responses across Trial 1, Trial 2, and the Retention Trial.  Essentially, it was found that 
malingerers with more coaching appear to be able to demonstrate a performance that is impaired yet 
more believable.  Coached malingerers may have better performance on symptom validity tests 
compared to naïve malingerers, but on consistency indices of measures such as the TOMM or WMT, 
coaching does not appear to improve performance (Davis et al., 2012).  The findings of Davis and 
colleagues (2012) suggest that examining consistency of responses on the TOMM may help detect 
malingering in cases where examinees are coached.  Jelicic and colleagues (201), using a sample of 
participants simulating malingering (n = 90) found that all participants instructed to give full effort 
were correctly classified, 97% of symptom-coached participants were correctly identified, and 87% of 
participants who were symptom and test-coached were correctly identified.  The findings of Jelicic and 
colleagues were consistent with previous studies such as a study by Powell, Gfeller, Hendricks, and 
Sharland (2004).  Although findings from studies with simulators may not perfectly generalize to 
clinical populations, the current evidence suggests that symptom validity tests, such as the TOMM will 
often still be efficacious despite coaching. 
Dedicated symptom validity test performance is often related to overall performance on 
neuropsychological tests.  Measured effort explained 53% of the variance in a study examining 30,736 
individual test scores (Green, Rohling, Lees-Haley, & Allen III., 2001).  In a study of 904 patients, 
including 470 patients with head injuries, Green and colleagues (2001) analyzed data from an average 
of 34 neuropsychological tests plus 2 symptom validity indicators.  Green and colleagues (2001) 
created an overall Symptom Validity score from scores on the Computerized Assessment of Response 
Bias (CARB; Allen, Conder, Green, & Cox, 1997), the Word Memory Test (WMT; Green, 2003), and 
the California Verbal Learning Test (CVLT; Delis, Kramer, Kaplan, & Ober, 1987) and compared this 
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validity score to an Overall Test Battery Mean which was designed to give an overall score to represent 
the global functioning of the individual by combining the average score of the patient across all 
measures.  It was found that the correlation between the Symptom Validity score and the Overall Test 
Battery Mean was 0.74 (Pearson’s r).  Green and colleagues (2001) found that the Symptom Validity 
score was a better correlate of overall performance compared to any other measured domain.  This 
study strongly suggests failure of symptom validity tests will likely indicate that scores on other 
neuropsychological tests are invalid.    
Gunner and colleagues (2012) found that suboptimal performance on symptom validity tests are 
related to decreased performance on neuropsychological memory tests.  Gunner and colleagues (2012) 
analyzed data from 48 patients who had evaluations for medico-legal reasons.  It was noted that all but 
5 patients had mild traumatic brain injury histories.  Gunner and colleagues used data from the HRNB 
(Reitan and Wolfson, 1993) the Memory Assessment Scales (MAS; Williams, 1991), the TOMM 
(Tombaugh, 1996), and the WMT (Green, 2003).  Gunner and colleagues (2012) used symptom validity 
test data to make a determination of optimal and suboptimal effort based upon TOMM performance 
alone, based upon WMT performance alone, based upon data from both the TOMM  and WMT, and an 
alternate interpretation of the TOMM known as the Albany Consistency Index (ACI; Gunner et al., 
2012).  It was found that 14.5% of the variance on the MAS Global Memory Index, which is a summary 
index of Short-term Memory, Verbal Memory, and Visual Memory,  could be accounted for by the 
ACI and 26.6% of the variance of the MAS Global Memory Index could be accounted for using just 
WMT criteria.  The relationship between the Global Memory Index and standard TOMM scores was 
nonsignificant.  Although variance accounted for Green and colleagues (2001) study and the Gunner 
and colleagues (2012) study had a noteworthy difference, it appears that the studies agree that 
performance on symptom validity tests are related to performance on neuropsychological tests.   
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There is data suggesting that performance on symptom validity tests can relate to performance 
on measures of personality.  Whitney (2012,), for example,  found that the Response Bias Scale on the 
Minnesota Multiphasic Personality Inventory-2 (MMPI-2; Butcher et al., 2001) accounted for about 
20% of the variance on TOMM scores.  This underscores that symptom validity test performance can 
be related to performance on almost all parts of a neuropsychological evaluation. 
Structured Interviews and Inventories Sensitive to Malingering 
Self-report behavior and personality rating scales can also be useful for detecting malingering.  
The Minnesota Multiphasic Personality Inventory – 2 (MMPI-2) can serve as a useful tool for 
determining if an examinee is falsely representing pathology (Toomey et al., 2009).  Scales on the 
MMPI-2 should not be considered in isolation as validity scales on the MMPI-2 accounted for less than 
26% of the variance on a Medical Symptom Validity Test (MSVT; Green, 2004) and less than 20% of 
the variance on the TOMM (Tombaugh, 1996) according to Whitney (2013).  Novo and colleagues 
(2013) established the MMPI-A had an excellent ability to classify adolescents who were malingering. 
 The Millon Clinical Multiaxial Inventory – III (MCMI-III; Millon, 1994) has demonstrated 
efficacy with detecting malingers; each validity indicator was able to detect about 50% of malingers in 
a group of TBI patients (Aguerrevere, Greve, Bianchini, & Ord, 2011).  Aguerrevere and colleagues 
(2011) utilized as participants 108 referrals to a psychology clinic.  The 108 referrals had varying 
degrees of reported TBIs from mild to severe and all but six referrals had a significant external 
incentive.  One participant was excluded due to psychiatric conditions.  The participants were 
administered the MCMI-III in a standard manner and were classified as having malingered 
neurocognitive dysfunction (MND), not having MND, or being in an indeterminate group using criteria 
developed by Slick and colleagues (1999).  To qualify as having MND, by the criteria of Slick and 
colleagues (1999), individuals must have an external incentive present (Criteria A), evidence from 
neuropsychological testing (Criteria B), evidence from self-report (Criteria C), and the presence of 
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behaviors in Criteria B and Criteria C must not be fully accounted for neurological, psychiatric, or 
developmental factors (Aguerrevere et al., 2011).  Aguerrevere and colleagues (2011) found that all of 
the MCMI-III modifier indices were useful in detecting malingerers and that by using all indices, 56% 
of malingerers were detected with no false positives.   
Structured interviews can be effective in identifying malingering.  According to Toomey and 
colleagues (2009), despite imperfect classification accuracy, the Structured Interview of Reported 
Symptoms (SIRS; Rogers, Bagby & Dickens, 1992) is regarded by some to be the most accurate 
measure for detecting malingering.  Unfortunately, structured interviews like the SIRS and open-ended 
interviews can sometimes take considerable time and resources to complete; therefore it is in the 
interest of clinicians and patients to use the most efficient and appropriate set of measures for the 
circumstances.  Smith and Burger (1997) suggested using malingering screening measures like the 
Structured Inventory of Malingered Symptomatology (SIMS) and examining results of personality 
inventories to screen for malingering prior to administration of extended measures such as the SIRS.  
Smith and Burger (1997) reached this conclusion via a study with college students (n = 476) divided 
into eight groups with various conditions of simulated malingering and full effort responding.  It was 
found that the SIMS had the highest level of sensitivity when compared to the F and K scales of the 
Minnesota Multiphasic Personality Inventory (MMPI), the 16PF Faking Bad scale, and portions of the 
malingering scale (Smith & Burger, 1997).  Smith and Burger (1997) pointed out the limitations of the 
study which included the fact that college students were asked to simulate malingering for some extra 
credit.     
Conclusions 
Malingering, which is often generally defined as exaggerating or feigning impairment in order 
to gain an external incentive, is a condition that neuropsychologists must be mindful of during the 
evaluation process.  Malingering has been present in some form throughout most of human history with 
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some of its earliest roots being in military history.  Malingering can be relatively uncommon in general 
healthcare settings but rather routine in forensic settings or other settings where notable incentives to 
malinger exist.  Malingering detection was often done by clinical instinct until more literature about 
using more objective tests appeared in the late 1970’s and beyond.  It is clear that malingering can 
impact the results of many common assessments used in neuropsychological evaluations, yet the 
literature suggests that analyzing test scores in the absence of data specifically related to symptom 
validity is often insufficient for detection of malingerers.   
A number of stand-alone symptom validity tests and embedded validity indicators exist to help 
a practitioner identify malingering; however, experts in the field routinely encourage practitioners to 
use the data in context of an entire evaluation.  Observations of the examinee, tests of physical 
functioning, and careful examination of medical records can sometimes aid in the detection of 
malingering.  Identification of malingerers can be difficult due to the imperfect measures available, 
examinees exhibiting malingering inconsistently during the evaluation, examinees being coached on 
how to defeat symptom validity measures, examiner mindsets, and examinees giving altered effort 
unintentionally.   
Research and practice related to malingering continues in hope of identifying better ways to 
classify malingering.  Currently, the literature provides a number of studies validating longstanding 
measures of symptom validity and some comparisons amongst measures, but to date the relationship 
between performance on dedicated symptom validity tests and some commonly administered 
neuropsychological tests has not been thoroughly elucidated. 
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Chapter III 
 
 
Methodology 
 The purpose of this chapter is to detail how participants were selected and describe procedures 
that were used to gather and analyze data.  This chapter is divided into four parts: Participant Selection; 
Data collection procedures; Instrumentation, Validity, and Reliability; and Data Analysis. 
 Participant Selection.  Participants for the study were recruited through a pool of general 
psychology students seeking to participate in psychological research; the research pool from 
Psychological Sciences at Ball State University was used.  Participants consisted of university students 
over the age of 18 who are enrolled in a psychology course at the undergraduate level.   A total of 46 
participants were recruited for the study.   
 Procedures.  All data collection from participants occurred in a manner consistent with 
procedures approved the university’s Institutional Review Board (IRB) for a study for which Dr. 
Andrew Davis is the primary investigator; Evaluating the Relationship between Memory, Intellectual 
Functioning, Executive Functioning, Language, Visual-Spatial/Construction, Attention and Effort.  The 
writer of this study and other graduate students participated in data collection using procedures 
approved by the IRB.  Data collection occurred in quiet, well-lit rooms.  Upon arrival participant 
arrival at a room, examiners reviewed the informed consent form with the participants who then signed 
an informed consent form.  Participants provided demographic data.  Collected demographic 
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information included participants’ age at testing, gender, ethnicity, handedness, level of education, 
parents’ level of education, parents’ occupation, current medications, psychiatric diagnoses, learning 
disabilities, and history of brain injury.  Prior to test administration, participants were read standard 
statements informed them of the nature of the following tasks and encouraged participants to put forth 
full effort during their session.  Through the reading of standard instructions, participants were 
informed that they may take breaks whenever they wish and that they could withdraw from the study at 
any time and for any reason.   
 Participants were administered neuropsychological assessments in a manner consistent with the 
standardized instructions present in the respective examiner’s manual of each assessment.  Participants 
were individually administered assessments in a quiet, well-lit room.  All participants were 
administered assessments by advanced graduate students who had successfully completed a class in 
cognitive assessment and additional training for administration of the specific assessments used in the 
study.  The current study examined results from a subset of the instruments in Dr. Davis’ study, the 
Test of Memory Malingering (TOMM; Tombaugh, 1996), Word Memory Test (WMT; Green, 2003), 
and the Wechsler Memory Scale - Fourth Edition (WMS-IV; Wechsler, 2009).  Administration time for 
the WMS-IV (Wechsler, 2009) is generally 90 minutes for the primary subtests (Drozdick, Holdnack, & 
Hilsabeck, 2011).  The administration time of the WMT (Green, 2003) is generally 10 to 15 minutes.  
The administration time of the TOMM (Tombaugh, 1996) is generally 15 to 20 minutes.  The 
administration time for the above measures factored into an expected total administration time of 
approximately four hours for the larger study.  Participants received 4 hours of research participation 
credit for their psychology course for taking part in the study.   
Instrumentation   
Test of Memory Malingering. The Test of Memory Malingering (TOMM; Tombaugh, 1996) is 
an assessment employed by psychologists to help determine if examinees are suffering from memory 
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impairment or providing insufficient effort.  The test appears to be a visual memory recognition task 
with two learning trials.  The test is designed to be resistant to a wide range of neurological 
impairments and sensitive to insufficient effort.  The TOMM can be administered by hand or via 
computer format.  The TOMM is administered to individual examinees and can be administered to 
individuals from 16 to 84 years of age.  The administration time for the TOMM is 15 to 20 minutes for 
standard administration. 
The development of the TOMM was based upon research in the fields of cognitive psychology 
and neuropsychology. In order to detect malingering behavior, the test was designed to appear difficult 
despite actually being simple. The development of the TOMM was based upon research, such as that 
conducted by Standing, Conezio, and Haber (1970), that demonstrated individuals (n = 2) who were 
shown 1,100 pictures for 5 seconds each could each recognize over 95% of presented pictures after a 
30 minute delay when these pictures were presented in pairs consisting of new and previously viewed 
pictures. 
 According to Tombaugh (1996) the initial normative testing for the TOMM was conducted on 
405 individuals who ranged in age from 16 to 84 years with an average of 13.1 years of education. This 
non-clinical sample was recruited via word of mouth and in public places such as shopping centers. 
Some participants received university course credit although none of the participants received financial 
compensation. Although the TOMM was modified after the initial normative testing, the sample could 
identify 94% of target images on the first trial and over 99% of target images on the second trial and 
retention trial. About 7.5% of variance on Trial 1 was accounted for by education and less than 2% of 
variance on the second trial and the retention trial was accounted for by education.  On all TOMM 
trials, individuals performed at levels higher than expected.  
 After adjustments were made to the TOMM, such as changing the number of distractors and 
changing the level of feedback, more normative data was collected from a non-clinical sample of 70 
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individuals with an age range of 17 to 73 years.  Participants in this sample had an average of 12.7 
years of education.  Comparable to the first phase of normative testing, participants had 95.6% 
accuracy on Trial 1 and over 99% accuracy on the other two trials.  Both phases of normative data 
collection demonstrated that TOMM performance for individuals without neurological impairment is 
high.  
Validation of the TOMM with a clinical sample was conducted using scores from 158 patients 
(after excluding data from 3 patients who were too impaired to test).  This clinical sample consisted of 
individuals with no cognitive impairment (n = 13), cognitive impairment (n = 42), aphasia (n = 21), 
traumatic brain injury (n = 45), and dementia (n = 40).  No patients in the clinical sample were 
involved in litigation or compensation hearings.  The resistance of the TOMM to influence from bona 
fide impairment was demonstrated by the findings of no significant difference in performance among 
the first four listed groups using an ANOVA and Tukey-HSD posttest.  The same analysis revealed the 
dementia group was significantly different; however, the dementia group was still able to obtain higher 
than 92% accuracy on Trial 2 compared to over 97% accuracy obtained by all of the other groups.   
To explore characteristics of the TOMM while being used with potential malingerers, a sample 
of 49 undergraduate students without known neurological impairment were recruited.  Students were 
either given instructions to perform with full effort (n = 22) or asked to simulate malingering (n = 27).  
The students asked to simulate malingering were given a week to prepare and were given a detailed 
scenario which provided coaching on how to convincingly demonstrate impairment.  Students were 
offered a reward of $50 for successfully malingering.  As expected the group instructed to perform with 
full effort generally had extremely high performance on the TOMM consist with the non-clinical 
normative studies described previously.  Using an accuracy cut-off score, 82% of simulated 
malingerers were correctly identified and 100% of students in the control group were correctly 
identified as providing adequate effort (Tombaugh, 1996). 
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Another study was conducted on a clinical sample with some patients who were “at-risk” for 
malingering.  This sample consisted of TBI (Traumatic Brain Injury) patients who were not “at-risk” 
for malingering (n = 17), TBI patients “at-risk” for malingering (n = 11), cognitively intact controls (n 
= 11), and patient controls with significant focal neuropsychological impairment recruited from a 
neurological unit (n = 12).  On Trial 2 and the Recognition trial, analysis with ANOVA and a Tukey-
HSD posttest revealed no significant difference among the three groups not determined to be “at-risk” 
for malingering.  The group “at-risk” for malingering, based upon meeting one or more predetermined 
criteria, had significantly different performance from the other three groups.  It was also determined 
that performance on select parts of the California Verbal Learning Test and Wechsler Memory Scale – 
Revised were relatively independent from TOMM performance which suggested little overlap in the 
constructs being measured.   
Word Memory Test.  The Word Memory Test (WMT; Green, 2005) is an assessment utilized by 
psychologists to measure verbal and nonverbal memory.  The WMT consists of multiple subtests 
intended to measure memory; these subtests contain embedded measures intended to determine validity 
of examinee performance.  The test is designed to be resistant to a wide range of neurological 
impairments and sensitive to insufficient effort.  The WMT is administered via computer; however, an 
oral form of the WMT is available for special circumstances.  The WMT is administered to individual 
examinees and can be administered to adults and children who have at least a 3
rd
 grade reading level.  
The administration time for the WMT is 10 to 15 minutes. 
The WMT normative group was collected by several practitioners in independent clinical 
settings in the U.S. and Canada.  The main normative sample consisted of data from 1,250 patients with 
some patients reporting head injury (n = 535), neurological patients with strokes, aneurysms, multiple 
sclerosis, and other conditions (n = 89), patients with major depression (n = 85), anxiety disorders (n = 
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18), orthopedic injuries (n = 77), chronic fatigue syndrome (n = 34), chronic pain syndrome or 
fibromyalgia (n = 61), and other conditions (n = 101).   
Validation of the WMT was based upon a study (Iverson, Green, & Gervais, 1999) with 40 
healthy volunteers and 57 patients with moderate to severe brain injuries.  Healthy volunteers had 
97.8% accuracy on the three WMT symptom validity measures whereas patients with brain injuries had 
95.1% accuracy.  This demonstrated relative insensitivity of the WMT to known  impairment.   
Another study conducted by Green & Allen (1999) with 40 neurological patients divided into 
high impairment and low impairment groups based upon California Verbal Learning Test impairment 
(CVLT; Delis, Kramar, Kaplan, & Ober, 1987) found no significant difference in WMT performance.  
Green (2005) noted that WMT subtests designed to measure memory were significantly lower in 
patients with impaired CVLT scores compared to patients with normal range CVLT scores.   
Gorissen, Sanz de la Torre, and Schmand (2003) found that German and Spanish translations of 
the WMT provided results consistent with the neurological patients and controls tested with the English 
version of the WMT.  It was found that for all three symptom validity measures, the Immediate Recall 
(IR), Delayed Recall (DR), and Consistency Scores, the control and neurologically impaired groups did 
not differ significantly in performance.   
Green, Iverson, and Allen (1999) found that in a large sample, individuals with greater head 
injury severity scores perform at a higher level than individuals with milder head injuries.  This 
suggested that the WMT was resistant to the effects of impairment and sensitive to exaggeration of 
deficits.   
Green (2005) noted that a study of 20 healthy volunteers provided test-retest reliability for the 
subtests of the WMT at r = 0.92 to r = 0.99 based upon subtest; however, in a clinical sample of 33 
patients tested with the WMT two times over the course of a year or more the test-retest reliability for 
IR and DR was 0.43 and 0.33 respectively.  It was suggested that the modest correlation was related to 
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varying effort rather than unreliability.  Cases with effort being satisfactory during testing and 
unsatisfactory during retesting were noted during the study of test-retest reliability of the clinical 
sample (Green, 2005). 
Iverson, Green, and Gervais (1999) demonstrated efficacy of the WMT with a simulator study.  
In this study, 25 highly educated and unimpaired individuals were asked to take the WMT and simulate 
genuine memory impairment without exaggerating to a point of being detectable.  While 40 healthy 
volunteers instructed to give full effort had an average of 97.8% accuracy on the WMT, the 25 
simulators had an average of 67.2% accuracy on the WMT symptom validity tests.  The simulators 
indicated trying to be subtle with impairment but scored more than 5 standard deviations lower than 
neurological patients on the DR measure.  
Green (2005) also cited another study with 20 patients who passed the WMT during a disability 
examination with 98.2% correct on average for the DR measure.  The individuals were asked to retake 
the WMT and simulate memory impairment with care being taken to not exaggerate to a degree that 
would be detectable.  The average performance upon retest was 62.6% accuracy.   
Green (2005) noted that the sensitivity of the WMT to exaggeration was 100% during the 
clinical study and 96% on the simulator study with well-educated volunteers.  All individuals instructed 
to give full effort on this simulator study were correctly classified as providing adequate effort.  The 
classification cutoff scores were set much lower than average scores of samples with brain injuries and 
samples of children with psychiatric illness so that the expected false positive rate for the WMT is 
expected to be extremely low.   
Wechsler Memory Scale – Fourth Edition.  The Wechsler Memory Scale – Fourth Edition 
(WMS-IV; Wechsler, 2009) is an assessment employed by psychologists to comprehensively test 
memory of individuals who have been diagnosed or suspected to have any number of neurological or 
psychiatric conditions.  The WMS-IV has subtests that can be added or removed from an assessment to 
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compose relevant test batteries.  The WMS-IV is administered orally to individual examinees and has 
normative data available for individuals who are 16 to 90 years old.  The administration time for the 
WMS-IV is 90 minutes for the primary subtests (Drozdick, Holdnack, & Hilsabeck, 2011).  According 
to the technical and interpretative manual of the WMS-IV (Wechsler, 2009), the normative sample for 
the WMS-IV normative sample consisted of 1,400 individuals.  There were 100 individuals divided in 
14 age bands from age 16 to 90.  Adults in the older age bands were administered a briefer battery 
designed for older adults.  Individuals in the normative sample were picked in such a way that 
individuals in each age band represented demographic data for gender and ethnicity on the 2005 U.S. 
Census.  The normative sample was also stratified based upon education level.  The sample was 
obtained from 480 examiners representing all of the major geographic regions of the U.S.  Start points 
and discontinue rules were set to ensure that examinees would not be exposed to a large number of 
excessively easy or excessively hard items.  Start points were set at a level where 95% of people at a 
given age would pass the initially presented items.   
Reliability of the WMS-IV was computed using split-half reliability based upon the Spearman-
Brown formula (Crocker & Algina, 1986; Li, Rosenthal, & Rubin, 1996) and internal consistency 
reliability for the WMS-IV was calculated using a formula from Nunnally and Bernstein (1994).  
Average reliability coefficients were calculated using Fisher’s z transformation (Silver & Dunlap, 
1987; Strube, 1988).  Internal consistency was not calculated for Verbal Paired Associates Word Recall 
Scaled Score and recognition memory measures as the number of items available to evaluate vary from 
individual to individual.   
The average split-half reliability for the WMS-IV index scores on the Adult battery ranged from 
0.93 to 0.96; similar reliability was reported for a sample of 555 individuals with a variety of clinical 
disorders (Drozdick, Holdnack, & Hilsabeck, 2011).  Reliability for subtests ranged from 0.82 to 0.97 
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in the Adult battery with slightly higher values found for the clinical sample (Drozdick, Holdnack, & 
Hilsabeck, 2011).   
Recognition memory tasks on the WMS-IV had restricted score ranges, so decision-consistency 
reliability was utilized to demonstrate reliability.  
WMS-IV Verbal Paired Associates I, Visual Reproduction I and II, and Spatial Addition had the 
highest internal consistency or reliability with other subtests being in the moderate to high range.  An 
examination of 555 individuals diagnosed with at least one of a number of psychiatric or neurological 
impairments revealed a high level of internal consistency for the WMS-IV and suggested its 
generalizability. 
The test-retest stability was examined by giving 244 individuals the WMS-IV on two occasions.  
The test-retest interval was from 14 to 84 days with a mean of 23 days.  The demographics of the 
sample were comparable to the general population demographics.  The corrected r for the first and 
second testing ranged from .59 to .81 based upon subtest.  The correction to r was applied to account 
for variability in the normative sample.  Some of the score differences in test-retest reliability were 
assumed to have occurred due to practice effects.  Interscorer agreement on more objectively scored 
parts of the WMS-IV ranged from .98 to .99.  On subtests with more subjective scoring guidelines (e.g. 
Clock Drawing), agreement was at 96% between two independent scorers. 
Validity was in part established by correlating the WMS-IV with the WMS-III.   A study 
examined the performance of individuals age 17 to 69 on both measures.  A total of 224 examinees 
were given both tests between 13 and 98 apart.  Since parts of the WMS-IV were significantly 
reworked, some indices had corrected correlation coefficients of .50 whereas some correlated at the .81 
level.  As expected, correlation of subtests with comparable subtests of the other measure was as low 
as .35.  Correlations with other popular memory tests, intelligence tests, and measures of interest were 
also computed to examine the concurrent validity of the WMS-IV.  Flanagan and Harrison (2012) note 
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that the correlations between the WMS-IV and WMS-III are high, but the reworking of visual 
components of the test lower correlations of the visual tests.  Correlation between the WMS-IV and 
measures examining similar constructs, such as the Children’s Memory Scale (Cohen, 1997) are high, 
whereas correlations between the WMS-IV and intelligence, achievement, or other measures are low to 
moderate (Flanagan & Harrison, 2012).  As an example, the WMS-IV and a measure of achievement, 
the Wechsler Individual Achievement Test (WIAT-II; Wechsler, 2005) have correlation coefficients 
ranging from 0.29 to 0.77 based upon indices measured. Construct validity was assessed via examining 
intercorrelations of subtest scores and comparing solutions of factor-analytic studies.  The technical and 
interpretive manual of the WMS-IV provides strong evidence for construct validity of the Auditory 
Memory Index (AMI), Visual Memory Index (VMI), and Visual Working Memory Index (VWMI); 
however, studies, such as a study conducted by Hoelzle, Nelson, and Smith (2011) found just two 
factors via principal component analysis conducted using data from the WMS-IV normative sample.  
Hoelzle and colleagues (2011) found that Logical Memory I & II and Verbal Paired Associates I & II 
load on an auditory component at 0.62 or higher whereas Designs I & II, Visual Reproduction I & II, 
Spatial Addition, and Symbol Span load on a visual component at 0.61 or higher; no subtest loaded on 
the other factor at higher than 0.24.  Content validity was assessed via direct questioning examinees on 
their response processes and looking for items that was often answered by respondents in an incorrect 
manner.  Adjustments to the test instructions, distractors, and items were made during test construction 
as needed.   
Restatement of Research Questions 
R1 How much variance in the WMS-IV subtests does the TOMM account for? 
R2 How much variance in the WMS-IV subtests does the WMT account for? 
R3 How much variance in the WMS-IV composites does the TOMM account for? 
R4 How much variance in the WMS-IV composites does the WMT account for? 
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R5 Does the examination of the means of all variables in the obtained sample look comparable to the 
means found in the literature? 
R6 How much correlation is present between TOMM and WMT scores? 
R7 How much correlation is present between WMS-IV, TOMM, and WMT scores? 
Data Analysis 
To understand the demographics and performance characteristics of the sample, descriptive 
statistics were used to understand average performance and the standard deviation for performance on 
the WMS-IV and subtests of the TOMM and WMT.   
Computation of a series of bivariate Pearson r coefficients were used to understand how each 
TOMM and each WMT subtest relate to the auditory memory and visual memory subtests of the 
WMS-IV in a univariate fashion, prior to examining these relationships in the context of the full model 
to be described below.   
To address research questions, a type of Structural Equation Modeling (SEM), known as path 
analysis was planned.  SEM is a set of statistical tools that allows for examination of how independent 
and dependent variables relate (Ullman, 2013).  The adequacy of SEM models for research questions 
was examined and presented using IBM® SPSS® Amos 19.0.  Models were presented to address the  
research questions to reduce model complexity and aid in the interpretation of how both autonomous 
symptom validity measures, the TOMM and WMT predicted performance on the WMS-IV.  As 
indicated in the figures, it was hypothesized that performance on the TOMM and WMT impacted 
performance on the WMS-IV rather than WMS-IV performance impacting the TOMM and WMT 
performance.  This directionality was assumed due to studies indicating that performance on the 
TOMM and WMT are generally not impacted by an array of conditions related to mental disorders or 
head injuries.  While usage of IBM® SPSS® Amos 19.0 was originally planned, relationships between 
  
SYMPTOM VALIDITY AND MEMORY 
 
63 
 
measures was explored using R i386 3.3.2 (R Core Team, 2013) with relevant add-on packages due to 
resource availability. 
Due to the TOMM and WMT consisting of tasks that appear to be assessing visual and auditory 
memory, respectively, it was expected that the relationships between each symptom validity measure 
and the subtests of the WMS-IV would be different.  It was expected that the TOMM would account 
for more variance in the visual memory subtests of the WMS-IV whereas the TOMM would account 
for more variance in the auditory memory subtests of the WMS-IV. 
In the models, as depicted in the figures, all variables were treated as observed variables.  The 
relationship between measures was explored primarily through multivariate regression.  Latent 
variables such as effort or the various types of memory were assumed to be represented by subtest 
performance and therefore were not be included in the models.  Multivariate regression often works 
best with sample sizes in the hundreds or thousands.  Techniques developed for statistics with low 
sample size (e.g. Bentler & Yuan, 1999) were considered while working with data acquired from the 46 
participants in the study.   
In order to address the first four research questions, multivariate regressions were used.  See 
figures 1 through 20.  The multivariate regressions explored how each predictor variable from the 
TOMM and WMT related to each observed variable of the WMS-IV subtests and WMS-IV 
composites. 
In order to address research question five, the means and standard deviations were computed for 
each predictor variable and each observed variable for the TOMM, WMT, and WMS-IV.  These values 
were explored in relationship to values obtained in the examiner’s manuals of each measure and other 
relevant literature available. 
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Research questions six and seven were explored by using Pearson and Spearman correlations.  
These values were compared to the literature as well as data obtained through the multivariate 
regressions used in the previous questions. 
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Figure 1:  Regression model exploring how TOMM Trial 1 relates to WMS-IV subtests.
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Figure 2:  Regression model exploring how TOMM Trial 2 relates to WMS-IV subtests. 
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Figure 3:  Regression model exploring how TOMM Trial 1 plus Trial 2 relate to WMS-IV subtests. 
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Figure 4:  Regression model exploring how WMT Immediate Recall relates to WMS-IV subtests. 
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Figure 5:  Regression model exploring how WMT Delayed Recall relates to WMS-IV subtests. 
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Figure 6:  Regression model exploring how WMT Consistency relates to WMS-IV subtests. 
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Figure 7:  Regression model exploring how WMT Multiple Choice relates to WMS-IV subtests. 
 
 
  
SYMPTOM VALIDITY AND MEMORY 
 
72 
 
Figure 8:  Regression model exploring how WMT Paired Associates relates to WMS-IV subtests. 
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Figure 9:  Regression model exploring how WMT Free Recall relates to WMS-IV subtests. 
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Figure 10:  Regression model exploring how WMT LD Free Recall relates to WMS-IV subtests.
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Figure 11:  Regression model exploring how TOMM Trial 1 relates to WMS-IV composites. 
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Figure 12:  Regression model exploring how TOMM Trial 2 relates to WMS-IV composites. 
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Figure 13:  Regression model exploring how TOMM Trial 1 plus 2 relates to WMS-IV composites. 
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Figure 14:  Regression model exploring how WMT Immediate Recall relates to WMS-IV composites. 
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Figure 15:  Regression model exploring how WMT Delayed Recall relates to WMS-IV composites. 
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Figure 16:  Regression model exploring how WMT Consistency relates to WMS-IV composites. 
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Figure 17:  Regression model exploring how WMT Multiple Choice relates to WMS-IV composites. 
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Figure 18:  Regression model exploring how WMT Paired Associates relates to WMS-IV composites. 
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Figure 19:  Regression model exploring how WMT Free Recall relates to WMS-IV composites. 
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Figure 20:  Regression model exploring how WMT LD Free Recall relates to WMS-IV composites. 
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Chapter IV 
RESULTS 
 
Results 
 The purpose of this study was to examine the relationship between measures of memory and 
measures of symptom validity testing.  Specifically, this study was designed to explore the possibility 
that data from a widely used test of memory could be used to predict performance on common 
symptoms validity tests.  Measures utilized in this study included data from the Wechsler Memory 
Scale, Fourth Edition (WMS-IV; Wechsler, 2009), the Word Memory Test (WMT; Green, 2003), and 
the Test of Memory Malingering (TOMM; Tombaugh, 1996).  In total, seven research questions 
exploring relationships between memory measures and symptom validity measures were addressed. 
 This chapter consisted of a description of the sample and a summary of how the results of 
statistical tests addressed the research questions, and conclusions.   
 Description of the Sample.  The sample consisted of 46 college students.  Participants were 
required to be at least 18 years of age and enrolled in a psychology class at a medium-sized Midwestern 
university.  Participants were awarded 4 hours of research participation credit for attending the study 
and were given the option to withdraw from the study at any time while still retaining full credit for 
participation.  In total, 1 participant withdrew from the study which left 45 usable sets of data.  Table 1 
presents demographic characteristics of participants in the present study.   
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Table 1: Demographic characteristics for the sample in the present study 
Variable        n = 46 
Mean age (SD)       19.91 (1.62)   
Gender 
Female       54%  
Male        46% 
Ethnicity 
 Caucasian/White      72% 
 Multiracial/Mixed      11% 
 African American/Black     9% 
 Asian        4% 
 Hispanic/Latino      4% 
Handedness 
 Right        83% 
 Left        17% 
Medical  
 On one or more medications/supplements    54% 
 Not on medications or supplements     46% 
 One or more physical/mental diagnoses   35% 
 No physical or mental diagnoses    65% 
 ADHD diagnosis       9% 
 No ADHD diagnosis      81% 
 LD diagnosis        4% 
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 No LD diagnosis      96% 
 TBI diagnosis       4% 
 No TBI diagnosis      96% 
Educational Attribute Means* 
 GPA (SD)     (n = 34)  2.80 (0.51) 
 SAT (SD)     (n = 26)  1621.81 (191.29) 
 ACT (SD)     (n = 20)  22.00 (3.51) 
 Years of education (SD)   (n = 46)  13.00 (1.30) 
 Mother’s years of education (SD)  (n = 45)  14.59 (2.38) 
 Father’s years of education (SD)  (n = 44)  14.49 (2.36) 
* = Specific educational attributes were not reported by some participants.  All other variables n = 46. 
Summary of the Results 
 The application of the results to the research questions will now be discussed. 
Regression Assumptions   
Valid usage of parametric tests, such as linear regression, require data to adhere to statistical 
assumptions.  Linear regression analyses require data to have multivariate normality, no significant 
multicollinearity, no auto-correlation, homoscedasticity, and a linear relationship.   
 Data adherence to assumptions was examined by using Q-Q Plots, quantitative information 
from the Mardia tests of multivariate skew and kurtosis in R (Mardia, 1970), and mean and standard 
deviation data.  WMS-IV variables appeared free from restricted ranges; however, some degree of 
skew and exponential distribution was evidenced in WMS-IV variables.  This was evidenced by Q-Q 
Plots (see figure 1) as well as mean and standard deviation data (see Table 23 on page 125).  Figure 1 
presents Verbal Paired Associates II, a WMS-IV subtest, which has data patterns representative of the 
other administered WMS-IV subtests. 
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Figure 1: Q-Q Plot for Verbal Paired Associates II (VPA2) 
 
 
 
 
 
 
 
 
 
 
 
 
 Non-linear data transformations may correct for observed non-linear data patterns; however, 
some predictor variables had data distributions that may not be manipulated sufficiently for usage with 
parametric tests.  Data for both TOMM trials had severely restricted ranges.  TOMM Trial 1 had a 
mean score of 48.98 and a standard deviation of 1.31.  For TOMM Trial 2, the sample had a mean 
score of 49.98 with a standard deviation of 0.16.   
 Some WMT predictor variables, specifically Multiple Choice (MC), Paired Associates (PR), 
Free Recall (FR), and Long Delayed Free Recall (LDFR) approached a normal and linear distribution; 
however, Immediate Recall (IR), Delayed Recall (DR), and Consistency (CNS) showed a curvilinear 
distribution and restricted ranges comparable to that observed with TOMM variables. Restricted ranges 
were evidenced by standard deviation and range data (see Table 23 on page 125).  Data distribution 
abnormalities were also apparent on Q-Q Plots such as the plot presented for DR (see Figure 2).   
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Figure 2: Q-Q Plot for WMT Delayed Recall (DR) 
 
 
 
 
 
 
 
 
 
 
 
 
Regression Results 
R1 How much variance in the WMS-IV subtests does the TOMM account for?     
 A multivariate linear regression was calculated to predict performance on subtest scores from 
the WMS-IV based on performance on TOMM Trial 1.  TOMM Trial 1 data was used as a predictor for 
WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of Logical Memory 
II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), Designs I (DE1), 
Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), Spatial Addition (SA), 
Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired Associates II 
Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), Designs II 
Content (DE2Con), and Designs II Spatial (DE2 Spa).  No statistically significant regression equation 
was found (F(16,21) = 1.2745, p < 0.2959), with an R
2
 of 0.041523.  Statistical significance for the 20 
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analyses was set at the 0.0025 level rather than the 0.05 level due to using a Bonferroni correction 
(Dunn, 1961) to control for Type I error.  Table 2 presents a regression model predicting WMS-IV 
subtest scores from TOMM Trial 1. 
Table 2: Regression model predicting WMS-IV subtest scores from TOMM Trial 1 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
TOMM1 0.50735 16  0.041523  0.2959   – 
   Coefficient   Standard Error  Test Statistic   p-value 
(Intercept)   -13.0723      15.3759    -0.850      0.401 
LM1 ~TOMM1          0.5007       0.3135     1.597      0.119 
 
(Intercept)  4.9880   14.3085  0.349   0.729 
LM2 ~ TOMM1 0.1205   0.2918    0.413   0.682 
 
(Intercept)    23.0361      14.0065     1.645      0.109 
VPA1 ~ TOMM1        -0.2503       0.2856    -0.877      0.387 
 
(Intercept)   13.14458     11.72159     1.121      0.270 
VPA2 ~ TOMM1       -0.03838      0.23901    -0.161      0.873 
 
(Intercept)   -10.2771      17.6315    -0.583      0.564 
DE1 ~ TOMM1          0.4378       0.3595     1.218      0.231 
 
(Intercept)   -13.3133      17.6709    -0.753      0.456 
DE2 ~ TOMM1          0.5029       0.3603     1.396      0.171 
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(Intercept)    24.4096      18.1380     1.346      0.187 
VR1 ~ TOMM1        -0.2816       0.3698    -0.761      0.451 
 
(Intercept)   15.74699     19.56104     0.805      0.426 
VR2 ~ TOMM1       -0.09951      0.39886    -0.249      0.804 
 
(Intercept)    12.1325      17.0220     0.713      0.481 
SA ~ TOMM1         -0.0290       0.3471    -0.084      0.934 
 
(Intercept)     1.7470      14.0719     0.124      0.902 
SP ~ TOMM1          0.1968       0.2869     0.686      0.497 
 
(Intercept)     -7.193       11.917   -0.604      0.550 
LM2Rec ~ TOMM1   0.224        0.243     0.922      0.363 
 
(Intercept)    2.19277      9.07457     0.242       0.81 
VPA2Rec ~ TOMM1 0.03525      0.18504     0.191       0.85 
 
(Intercept)    7.56627     15.30311     0.494      0.624 
DE1Con ~ TOMM1   0.07809      0.31204     0.250      0.804 
 
(Intercept)    17.8072      21.1693     0.841      0.406 
DE1Spa ~ TOMM1    -0.1464       0.4317    -0.339      0.737 
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(Intercept)    -1.6265      17.0530    -0.095      0.925 
DE2Con ~TOMM1    0.2651       0.3477     0.762      0.451 
 
(Intercept)    6.95181     20.21590     0.344      0.733 
DE2Spa ~ TOMM1    0.07452      0.41221     0.181      0.858 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on TOMM Trial 2.  TOMM Trial 2 data was used as a predictor for 
WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of Logical Memory 
II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), Designs I (DE1), 
Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), Spatial Addition (SA), 
Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired Associates II 
Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), Designs II 
Content (DE2Con), and Designs II Spatial (DE2 Spa).   No statistically significant regression equation 
was found (F(16,21) = 0.89061, p < 0.5877), with an R
2
 of 0.031853. Table 3 presents a regression 
model predicting WMS-IV subtest scores from TOMM Trial 2. 
Table 3: Regression model predicting WMS-IV subtest scores from TOMM Trial 2 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
TOMM2 0.59575 16  0.031853  0.5877   – 
   Coefficient   Standard Error  Test Statistic   p-value 
(Intercept)    -64.162      125.550    -0.511      0.612 
LM1 ~ TOMM2          1.514        2.512     0.602      0.551 
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(Intercept)    -86.351      112.580    -0.767      0.448 
LM2 ~ TOMM2          1.946        2.253     0.864      0.393 
 
(Intercept)     74.243      111.756     0.664      0.511 
VPA1 ~ TOMM2        -1.270        2.236     -0.568     0.574 
 
(Intercept)    -2.2432      92.9627    -0.024      0.981 
VPA2 ~ TOMM2         0.2703       1.8602     0.145      0.885 
 
(Intercept)    207.027      138.891     1.491      0.145 
DE1 ~ TOMM2         -3.919        2.779    -1.410      0.167 
 
(Intercept)     96.432      143.178     0.674      0.505 
DE2 ~ TOMM2         -1.703        2.865     -0.594     0.556 
 
(Intercept)    184.838      142.057     1.301      0.201 
VR1 ~ TOMM2         -3.486        2.843     -1.227      0.228 
 
(Intercept)    325.568      146.133     2.228     0.0322  
VR2 ~ TOMM2         -6.297        2.924     -2.154     0.0380  
 
(Intercept)    128.216     133.576      0.96       0.344 
SA ~ TOMM2          -2.351       2.673     -0.88      0.385 
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(Intercept)    42.4595     112.2031    0.378      0.707 
SP ~ TOMM2         -0.6216       2.2452    -0.277      0.783 
 
(Intercept)    168.568       91.585     1.841     0.0739  
LM2Rec ~ TOMM2    -3.297        1.833     -1.799     0.0804  
 
(Intercept)   -43.3514      71.5687    -0.606      0.548 
VPA2Rec ~ TOMM2   0.9459       1.4321     0.661      0.513 
 
(Intercept)    42.4595     121.3546     0.350      0.728 
DE1Con ~ TOMM2    -0.6216       2.4284    -0.256      0.799 
 
(Intercept)    337.486      159.079     2.122     0.0408  
DE1Spa ~ TOMM2    -6.541        3.183     -2.055     0.0472  
 
(Intercept)    43.7838     136.2168     0.321      0.750 
DE2Con ~ TOMM2    -0.6486       2.7258    -0.238      0.813 
 
(Intercept)   133.514      159.079     0.839      0.407 
DE2Spa ~ TOMM2     -2.459        3.183     -0.773      0.445 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on a summation of performance on TOMM Trial 1 and TOMM Trial 2.  A summation 
of TOMM Trial data was used as a predictor for WMS-IV subtest score dependent variables.  WMS-IV 
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subtest score data consisted of Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal 
Paired Associates II (VPA2), Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual 
Reproduction II (VR2), Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition 
(LM2Recog), Verbal Paired Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), 
Designs I Spatial (DE1Spa), Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  No 
statistically significant regression equation was found (F(16,21) = 1.3988, p < 0.2326), with an R
2
 of 
0.04433. Table 4 presents a regression model predicting WMS-IV subtest scores from the sum of 
TOMM Trial 1 and 2. 
Table 4: Regression model predicting WMS-IV subtest scores from the sum of TOMM Trial 1 and 2 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
ALLT 0.48409 16  0.044330  0.2326   –  
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   -41.4401      31.1666    -1.330     0.1920   
LM1 ~ ALLT         0.5345       0.3148     1.698     0.0982  
 
(Intercept)    -4.4673      29.0844    -0.154      0.879 
LM2 ~ ALLT        0.1552       0.2938     0.528     0.601 
 
(Intercept)    38.0735      28.4539     1.338      0.189 
VPA1 ~ ALLT       -0.2759       0.2874    -0.960      0.344 
 
(Intercept)   14.67695     23.86345     0.615      0.542 
VPA2 ~ ALLT -0.03448      0.24103    -0.143      0.887 
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(Intercept)   -26.3675      36.0853    -0.731      0.470 
DE1 ~ ALLT        0.3793       0.3645     1.041      0.305 
 
(Intercept)   -36.4510      36.0638    -1.011      0.319 
DE2 ~ ALLT   0.4828       0.3643     1.325      0.193 
 
(Intercept)    44.7432      36.7822     1.216      0.232 
VR1 ~ ALLT       -0.3448       0.3715    -0.928      0.359 
 
(Intercept)    31.3512      39.7084     0.790      0.435 
VR2 ~ ALLT  -0.2069       0.4011    -0.516      0.609 
 
(Intercept)   17.53811     34.63643     0.506      0.616 
SA ~ ALLT      -0.06897      0.34984    -0.197      0.845 
 
(Intercept)    -7.3811      28.6625    -0.258      0.798 
SP ~ ALLT  0.1897       0.2895     0.655      0.517 
 
(Intercept)   -13.2795      24.3785    -0.545      0.589 
LM2Rec ~ ALLT       0.1724       0.2462     0.700      0.488 
 
(Intercept)   -1.19964     18.46273    -0.065      0.949 
VPA2Rec ~ ALLT      0.05172      0.18648     0.277      0.783 
 
  
SYMPTOM VALIDITY AND MEMORY 
 
97 
 
(Intercept)    4.56715     31.15891     0.147      0.884 
DE1Con ~ ALLT       0.06897      0.31471     0.219      0.828 
 
(Intercept)    36.2350      42.9516     0.844      0.404 
DE1Spa ~ ALLT      -0.2586       0.4338    -0.596      0.555 
 
(Intercept)   -14.2350      34.7327    -0.410      0.684 
DE2Con ~ ALLT        0.2586       0.3508     0.737      0.466 
 
(Intercept)    7.19147     41.16834     0.175      0.862 
DE2Spa ~ ALLT       0.03448      0.41581     0.083      0.934 
* = Significant at 0.0025 level 
R2 How much variance in the WMS-IV subtests does the WMT account for?  
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Immediate Recall.  WMT Immediate Recall data was used as 
a predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of 
Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), 
Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), 
Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  No statistically significant regression 
equation was found (F(16,24) = 1.4183, p < 0.2137), with an R
2
 of 0.040743. Table 5 presents a 
regression model predicting WMS-IV subtest scores from WMT Immediate Recall. 
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Table 5: Regression model predicting WMS-IV subtest scores from WMT Immediate Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
IR  0.514  16  0.040743  0.2137   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)  -4.0846       8.8501    -0.462     0.6470   
LM1 ~ IR         0.1591       0.0902     1.764     0.0856  
 
(Intercept)   -7.24667      7.55003    -0.960      0.343   
LM2 ~ IR            0.18664      0.07695     2.425      0.020  
 
(Intercept)   -0.92458      8.17709    -0.113      0.911 
VPA1 ~ IR            0.11916      0.08334     1.430      0.161 
 
(Intercept)   -5.30532      6.35921    -0.834     0.4092   
VPA2 ~ IR            0.16808      0.06482     2.593     0.0133 
 
(Intercept)   -14.76151      9.70418    -1.521     0.1363   
DE1 ~ IR             0.26430      0.09891     2.672     0.0109 
 
(Intercept)   -11.48917      9.54724    -1.203     0.2361   
DE2 ~ IR             0.23166      0.09731     2.381     0.0223 
 
(Intercept)   -10.1872      10.2123    -0.998     0.3247   
VR1 ~ IR             0.2102       0.1041     2.019     0.0504  
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(Intercept)    -6.0548      10.6809    -0.567      0.574 
VR2 ~ IR             0.1715       0.1089     1.575      0.123 
 
(Intercept)   -16.98099      9.08632    -1.869    0.06917   
SA ~ IR             0.28072      0.09261     3.031     0.00431 
 
(Intercept)   -8.24419      7.46285    -1.105     0.2761   
SP ~ IR            0.20155      0.07606     2.650     0.0116  
 
(Intercept)    4.249327     7.068457     0.601      0.551 
LM2Rec ~ IR           -0.004036     0.072045    -0.056      0.956 
 
(Intercept)    7.66032      5.21018     1.470      0.150 
VPA2Rec ~ IR          -0.03809      0.05310    -0.717      0.478 
  
(Intercept)   -3.30842      8.34416    -0.396     0.6939   
DE1Con ~ IR            0.14945      0.08505     1.757     0.0867  
 
(Intercept)   -11.0742      11.9226    -0.929     0.3587   
DE1Spa ~ IR             0.2212       0.1215     1.820     0.0764  
 
(Intercept)   -2.89247      9.38552    -0.308      0.760 
DE2Con  ~ IR            0.14521      0.09566     1.518      0.137 
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(Intercept)    -5.8334      11.1587    -0.523      0.604 
DE2Spa ~ IR             0.1663       0.1137     1.462      0.152 
* = Significant at 0.0025 level 
 A multivariate linear regression was calculated to predict performance on subtest scores from 
the WMS-IV based on performance on WMT Delayed Recall.  WMT Delayed Recall data was used as 
a predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of 
Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), 
Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), 
Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).   No statistically significant 
regression equation was found (F(16,24) = 1.9006, p < 0.07522), with an R
2
 of 0.049869. Table 6 
presents a regression model predicting WMS-IV subtest scores from WMT Delayed Recall. 
Table 6: Regression model predicting WMS-IV subtest scores from WMT Delayed Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
DR  0.4411  16  0.049869  0.07522   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)    -7.9510      13.3328    -0.596      0.554 
LM1~ DR             0.1964       0.1345     1.460      0.152 
 
(Intercept)    -9.8916      11.5834    -0.854     0.3983   
LM2 ~ DR             0.2113       0.1168     1.809     0.0782 
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(Intercept)    -8.1058      12.1190    -0.669      0.508 
VPA1 ~ DR             0.1903       0.1222     1.557      0.128 
 
(Intercept)   -16.92547      9.21137    -1.837    0.07377  
VPA2 ~ DR             0.28352      0.09292     3.051     0.00409 
 
(Intercept)   -23.3708      14.7109    -1.589     0.1202   
DE1 ~ DR             0.3483       0.1484     2.347     0.0241  
 
(Intercept)   -10.7304      14.8009    -0.725      0.473 
DE2 ~ DR             0.2215       0.1493     1.484      0.146 
 
(Intercept)   -18.9064      15.2743    -1.238     0.2232   
VR1 ~ DR             0.2959       0.1541     1.920     0.0621  
 
(Intercept)   -11.1493      16.0213    -0.696      0.491 
VR2 ~ DR             0.2210       0.1616     1.368      0.179 
 
(Intercept)   -38.7227      12.8015    -3.025    0.004386  
SA ~ DR             0.4971       0.1291     3.849    0.000428  
 
(Intercept)    -8.2554      11.6475    -0.709     0.4827   
SP ~ DR             0.1995       0.1175     1.698     0.0975  
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(Intercept)    9.45805     10.48636     0.902      0.373 
LM2Rec ~ DR          -0.05655      0.10578    -0.535      0.596 
 
(Intercept)    9.31596      7.76062     1.200      0.237 
VPA2Rec ~ DR          -0.05438      0.07828    -0.695      0.491 
 
(Intercept)    1.71378     12.81372     0.134      0.894 
DE1Con ~ DR            0.09715      0.12925     0.752      0.457 
 
(Intercept)   -22.4302      17.7168    -1.266     0.2130   
DE1Spa ~ DR            0.3334       0.1787     1.866     0.0696  
 
(Intercept)    6.88764     14.36337      0.48       0.634 
DE2Con ~ DR           0.04494      0.14488      0.31       0.758 
 
(Intercept)    -9.0592      16.7743    -0.540      0.592 
DE2Spa ~ DR            0.1970       0.1692     1.164      0.251 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Consistency.  WMT Consistency data was used as a 
predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of 
Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), 
Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), 
Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
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Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  No statistically significant regression 
equation was found (F(16,24) = 1.2062, p < 0.3305), with an R
2
 of 0.03621.  Table 7 presents a 
regression model predicting WMS-IV subtest scores from WMT Consistency. 
Table 7: Regression model predicting WMS-IV subtest scores from WMT Consistency 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
CNS  0.55427 16  0.03621  0.3305    – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   -2.33733      9.12155    -0.256      0.799 
LM1 ~ CNS           0.14164      0.09321     1.520      0.137 
 
(Intercept)   -6.39738      7.78087    -0.822     0.4160   
LM2 ~ CNS           0.17842      0.07951     2.244     0.0306  
 
(Intercept)   -2.97684      8.27554    -0.360      0.721 
VPA1 ~ CNS           0.14045      0.08456     1.661      0.105 
 
(Intercept)   -5.71015      6.48745    -0.880      0.384   
VPA2 ~ CNS           0.17264      0.06629     2.604      0.013  
 
(Intercept)   -14.5389       9.9575    -1.460     0.1523   
DE1 ~CNS            0.2627       0.1017     2.582     0.0137 
 
(Intercept)    -7.7529       9.9770    -0.777     0.4418   
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DE2 ~ CNS            0.1940       0.1019     1.903     0.0644 
 
(Intercept)   -11.2747      10.3901    -1.085     0.2845   
VR1 ~ CNS            0.2218       0.1062     2.089     0.0433 
 
(Intercept)    -7.0328      10.8773    -0.647      0.522 
VR2 ~CNS            0.1819       0.1111     1.637      0.110 
   
(Intercept)   -15.22283      9.44767    -1.611    0.11518    
SA ~ CNS            0.26344      0.09654     2.729     0.00948  
 
(Intercept)   -4.51015      7.86703    -0.573     0.5697   
SP ~ CNS           0.16386      0.08039     2.038     0.0483  
 
(Intercept)   3.030460     7.214634     0.420      0.677 
LM2Rec ~ CNS         0.008419     0.073721     0.114      0.910 
 
(Intercept)    9.38185      5.28170     1.776     0.0835  
VPA2Rec ~ CNS        -0.05579      0.05397    -1.034     0.3076   
 
(Intercept)   -4.31345      8.48545    -0.508     0.6141   
DE1Con ~ CNS          0.16010      0.08671     1.846     0.0724  
 
(Intercept)    -9.5957      12.2567    -0.783      0.438 
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DE1Spa ~ CNS           0.2066       0.1252     1.650      0.107 
 
(Intercept)   -1.56121      9.64051    -0.162      0.872 
DE2Con ~ CNS          0.13196      0.09851     1.340      0.188 
 
(Intercept)    -0.5703      11.5644    -0.049      0.961 
DE2Spa ~ CNS           0.1128       0.1182     0.955      0.345 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Multiple Choice.  WMT Multiple Choice data was used as a 
predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of 
Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), 
Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), 
Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  A statistically significant regression 
equation was found (F(16,24) = 2.2879, p < 0.03247), with an R
2
 of 0.056252.  This suggests that 
WMT Multiple Choice scores account for over 5% of the variance in WMS-IV subtest scores.  Table 8 
presents a regression model predicting WMS-IV subtest scores from WMT Multiple Choice. 
Table 8: Regression model predicting WMS-IV subtest scores from WMT Multiple Choice 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
MC  0.396  16  0.056252  0.03247   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)    7.13225      4.13726     1.724     0.0926  
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LM1 ~ MC            0.04683      0.04404     1.063     0.2942   
 
(Intercept)    2.24491      3.41430     0.658     0.5147   
LM2 ~ MC            0.09412      0.03634     2.590     0.0134  
 
(Intercept)   -0.22492      3.39653    -0.066     0.9475    
VPA1 ~ MC            0.11740      0.03616     3.247     0.0024  
 
(Intercept)    1.84639      2.76143     0.669     0.50766    
VPA2 ~ MC            0.09969      0.02940     3.391     0.00161 
 
(Intercept)   -0.83895      4.41447    -0.190    0.85026    
DE1 ~ MC            0.12813      0.04699     2.727     0.00953 
 
(Intercept)    1.65694      4.40187     0.376     0.7086   
DE2 ~ MC            0.10223      0.04686     2.182     0.0352  
 
(Intercept) -  2.65556      4.42401    -0.600    0.55180    
VR1 ~ MC            0.13973      0.04709     2.967     0.00511 
 
(Intercept)    2.78056      4.86059     0.572      0.571 
VR2 ~ MC            0.08527      0.05174     1.648      0.107 
 
(Intercept)   -2.30270      4.12086    -0.559    0.57950    
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SA ~ MC            0.13726      0.04387     3.129     0.00331 
 
(Intercept)    5.93005      3.58901     1.652      0.107 
SP ~ MC            0.05968      0.03820     1.562      0.126 
 
(Intercept)    5.62030      3.21332     1.749     0.0881  
LM2Rec ~ MC          -0.01889      0.03421    -0.552     0.5840   
  
(Intercept)    7.51509      2.32271     3.235     0.00248 
VPA2Rec ~ MC          -0.03836      0.02473    -1.552    0.12885    
 
(Intercept)    6.06720      3.86377     1.570      0.124 
DE1Con ~ MC           0.05639      0.04113     1.371      0.178 
 
(Intercept)   -0.25764      5.39118    -0.048     0.9621   
DE1Spa ~ MC           0.11618      0.05739     2.024     0.0498  
 
(Intercept)    6.96885      4.35138     1.602      0.117 
DE2Con ~ MC           0.04675      0.04632     1.009      0.319 
 
(Intercept)    0.91183      4.99929     0.182     0.8562   
DE2Spa ~ MC           0.10212      0.05322     1.919     0.0623  
* = Significant at 0.0025 level 
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A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Paired Associates.  WMT Paired Associates data was used as 
a predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of 
Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), 
Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), 
Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  No statistically significant regression 
equation was found (F(16,24) = 2.0906, p < 0.04972), with an R
2
 of 0.053092.  Table 9 presents a 
regression model predicting WMS-IV subtest scores from WMT Paired Associates. 
Table 9: Regression model predicting WMS-IV subtest scores from WMT Paired Associates 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
PR  0.41776 16  0.053092  0.04972   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   6.78485      3.81282     1.779      0.083  
LM1 ~ PR              0.05061      0.04061     1.246      0.220   
 
(Intercept)    3.35859      3.19276     1.052     0.2993   
LM2 ~ PR            0.08232      0.03401     2.421     0.0202 
 
(Intercept)     0.4616       3.1357     0.147     0.88372    
VPA1 ~ PR              0.1102       0.0334     3.300     0.00208 
 
(Intercept)    1.08384      2.41644     0.449    0.656256     
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VPA2 ~ PR            0.10798      0.02574     4.195    0.000152 
 
(Intercept)   -0.57609      4.04409    -0.142    0.88746    
DE1 ~ PR            0.12549      0.04307     2.913     0.00589  
 
(Intercept)    1.30875      4.01443     0.326     0.7462   
DE2 ~ PR            0.10609      0.04276     2.481     0.0175  
   
(Intercept)    -3.4340       3.9525    -0.869    0.39026    
VR1 ~ PR             0.1482       0.0421     3.521     0.00111 
  
(Intercept)    0.20370      4.33639     0.047     0.9628   
VR2 ~ PR            0.11296      0.04619     2.446     0.0191  
  
(Intercept)   -1.84007      3.77704    -0.487    0.62886    
SA ~ PR            0.13249      0.04023     3.293     0.00211 
 
(Intercept)    4.33468      3.22683     1.343     0.1869   
SP ~ PR             0.07684      0.03437     2.236     0.0312  
 
(Intercept)    7.45185      2.93185     2.542     0.0151  
LM2Rec ~ PR             -0.03852     0.03123    -1.233     0.2248   
   
(Intercept)    5.72593      2.19823     2.605     0.0129  
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VPA2Rec ~ PR          -0.01926      0.02341    -0.823     0.4158   
 
(Intercept)    5.48182      3.54130     1.548      0.130 
DE1Con ~ PR             0.06273      0.03772     1.663      0.104 
 
(Intercept)   -0.98687      4.90747    -0.201     0.8417   
DE1Spa ~ PR              0.12414      0.05227     2.375     0.0226  
 
(Intercept)    5.48182      3.97312     1.380      0.176 
DE2Con ~ PR             0.06273      0.04232     1.482      0.146 
 
(Intercept)    0.78855      4.58812     0.172     0.8644   
DE2Spa ~ PR              0.10357      0.04887     2.119     0.0405  
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Free Recall.  WMT Free Recall data was used as a predictor 
for WMS-IV subtest score dependent variables.  WMS-IV subtest score data consisted of Logical 
Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired Associates II (VPA2), Designs I 
(DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual Reproduction II (VR2), Spatial 
Addition (SA), Symbol Span (SP), Logical Memory II Recognition (LM2Recog), Verbal Paired 
Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), Designs I Spatial (DE1Spa), 
Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).   No statistically significant 
regression equation was found (F(16,24) = 1.4305, p < 0.2083), with an R
2
 of 0.040994.  Table 10 
presents a regression model predicting WMS-IV subtest scores from WMT Free Recall. 
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Table 10: Regression model predicting WMS-IV subtest scores from WMT Free Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
FR  0.51185 16  0.040994  0.2083    – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   8.17510      1.77628     4.602    4.35e-05  
LM1 ~ FR            0.05146      0.02678     1.921      0.062  
 
(Intercept)   7.01307      1.49742     4.683    3.38e-05  
LM2 ~ FR            0.06223      0.02258     2.756     0.00885   
  
(Intercept)   7.79230      1.62426     4.797    2.37e-05 
VPA1 ~ FR            0.04570      0.02449     1.866     0.0696   
 
(Intercept)   8.10456      1.29774     6.245    2.36e-07 
VPA2 ~ FR            0.04728      0.01957     2.416     0.0205    
   
(Intercept)    8.64702      2.09342     4.131    0.000185 
DE1 ~ FR            0.03854      0.03156     1.221    0.229426     
  
(Intercept)   9.94626      2.05424     4.842    2.06e-05  
DE2 ~ FR            0.01963      0.03097     0.634       0.53     
 
(Intercept)   6.35273      2.06443     3.077     0.00381  
VR1 ~ FR            0.06263      0.03113     2.012     0.05114   
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(Intercept)   5.31657      2.04007     2.606     0.01290   
VR2 ~ FR            0.08387      0.03076     2.727     0.00953  
 
(Intercept)   6.96875      1.95567     3.563    0.000985 
SA ~ FR            0.05501      0.02949     1.866    0.069613   
    
(Intercept)   10.04419      1.62053     6.198    2.75e-07  
SP ~ FR            0.02264      0.02443     0.926       0.36     
 
(Intercept)    5.45942      1.40408     3.888    0.000382 
LM2Rec ~ FR            -0.02476      0.02117    -1.170    0.249266     
   
(Intercept)    4.70102      1.05221     4.468     6.6e-05  
VPA2Rec ~ FR          -0.01194      0.01586    -0.752      0.456     
  
(Intercept)   10.04581      1.73882     5.777    1.06e-06 
DE1Con ~ FR            0.01998      0.02622     0.762      0.451     
 
(Intercept)   8.10403      2.47588     3.273     0.00223  
DE1Spa ~ FR            0.03864      0.03733     1.035     0.30704    
  
(Intercept)   10.44751      1.94640     5.368     3.9e-06  
DE2Con ~ FR            0.01378      0.02935     0.470      0.641     
  
SYMPTOM VALIDITY AND MEMORY 
 
113 
 
 
(Intercept)    9.42410      2.30969      4.08    0.000215 
DE2Spa ~ FR              0.01603      0.03482      0.46    0.647937     
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on subtest scores from the 
WMS-IV based on performance on WMT Long Delayed Free Recall.  WMT Long Delayed Free Recall 
data was used as a predictor for WMS-IV subtest score dependent variables.  WMS-IV subtest score 
data consisted of Logical Memory II (LM2), Verbal Paired Associates I (VPA1), Verbal Paired 
Associates II (VPA2), Designs I (DE1), Designs II (DE2), Visual Reproduction I (VR1), Visual 
Reproduction II (VR2), Spatial Addition (SA), Symbol Span (SP), Logical Memory II Recognition 
(LM2Recog), Verbal Paired Associates II Recognition (VPA2Recog), Designs I Content (DE1Con), 
Designs I Spatial (DE1Spa), Designs II Content (DE2Con), and Designs II Spatial (DE2 Spa).  No 
statistically significant regression equation was found (F(16,24) = 0.86505, p < 0.6108), with an R
2
 of 
0.028057.  Table 11 presents a regression model predicting WMS-IV subtest scores from WMT Long 
Delayed Free Recall. 
Table 11: Regression model predicting WMS-IV subtest scores from WMT Long Delayed Free Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
LDFR  0.63424 16  0.028057  0.6108    – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)    8.31561      1.83903     4.522    5.59e-05  
LM1 ~ LDFR              0.04843      0.02728     1.775     0.0836  
 
(Intercept)    6.83511      1.53637     4.449      7e-05  
LM2 ~ LDFR           0.06384      0.02279     2.801     0.00788  
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(Intercept)    7.16635      1.64218     4.364    9.09e-05 
VPA1 ~ LDFR           0.05439      0.02436     2.233     0.0314    
  
(Intercept)    8.53825      1.36523     6.254     2.3e-07 
VPA2 ~ LDFR           0.03989      0.02025     1.969      0.056   
  
(Intercept)    8.62497      2.15531     4.002    0.000272 
DE1 ~ LDFR           0.03820      0.03197     1.195    0.239356     
  
(Intercept)   10.01438      2.11502     4.735    2.88e-05  
DE2 ~ LDFR          0.01826      0.03137     0.582      0.564     
 
(Intercept)    7.25224      2.17055     3.341     0.00185  
VR1 ~ LDFR           0.04792      0.03220     1.488     0.14476    
 
(Intercept)    7.08088      2.20980     3.204     0.0027  
VR2 ~ LDFR           0.05569      0.03278     1.699     0.0973   
 
(Intercept)    7.15197      2.02550     3.531     0.00108 
SA ~ LDFR           0.05128      0.03005     1.707     0.09582  
 
(Intercept)   11.050657     1.683692     6.563    8.57e-08 
SP ~ LDFR          0.006993     0.024976     0.280      0.781     
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(Intercept)     4.69981      1.46304     3.212     0.00264  
LM2Rec ~ LDFR        -0.01282      0.02170    -0.591    0.55811    
 
(Intercept)     4.302898     1.088568     3.953    0.000315 
VPA2Rec ~ LDFR       -0.005698     0.016148    -0.353   0.726093     
 
(Intercept)    9.71753      1.78242     5.452    2.98e-06  
DE1Con ~ LDFR         0.02461      0.02644     0.931      0.358     
  
(Intercept)    7.77215      2.53979     3.060     0.00399  
DE1Spa ~ LDFR         0.04299      0.03768     1.141     0.26076    
 
(Intercept)   10.58933      2.00427     5.283     5.1e-06  
DE2Con ~ LDFR         0.01140      0.02973     0.383      0.704     
 
(Intercept)    9.24974      2.37428     3.896    0.000373 
DE2Spa ~ LDFR         0.01839      0.03522     0.522    0.604547     
* = Significant at 0.0025 level 
R3 How much variance in the WMS-IV composites does the TOMM account for? 
   A multivariate linear regression was calculated to predict performance on composite scores 
from the WMS-IV based on performance on TOMM Trial 1.    TOMM Trial 1 data was used as a 
predictor for WMS-IV composite score dependent variables.  WMS-IV composite score data consisted 
of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working Memory Index 
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(VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No statistically 
significant regression equation was found (F(5,32) = 0.058231, p < 0.9976), with an R
2
 of 0.001811.  
Table 12 presents a regression model predicting WMS-IV index scores from TOMM Trial 1. 
Table 12: Regression model predicting WMS-IV index scores from TOMM Trial 1 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
TOMM1 0.99098 5  0.001811  0.9975   – 
   Coefficient   Standard Error  Test Statistic   p-value 
(Intercept)     84.181       62.775     1.341      0.188 
AMI ~ TOMM1           0.452        1.280     0.353      0.726 
 
(Intercept)     61.398       92.849     0.661      0.513 
VMI ~ TOMM1           0.913        1.893     0.482      0.633 
 
(Intercept)     81.349       76.929     1.057      0.297 
VWMI ~ TOMM1        0.506        1.569     0.323      0.749 
 
(Intercept)    74.4337      77.0973     0.965      0.341 
IMI ~ TOMM1            0.6627       1.5721     0.422      0.676 
 
(Intercept)     66.7349      79.1975     0.843      0.405 
DMI ~ TOMM1           0.8358       1.6149     0.518      0.608 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on TOMM Trial 2.  TOMM Trial 2 data was used as a predictor for 
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WMS-IV composite score dependent variables.  WMS-IV composite score data consisted of the 
Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working Memory Index 
(VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No statistically 
significant regression equation was found (F(5,32) = 1.338, p < 0.2736), with an R
2
 of 0.037257.  Table 
13 presents a regression model predicting WMS-IV index scores from TOMM Trial 2. 
Table 13: Regression model predicting WMS-IV index scores from TOMM Trial 2 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
TOMM2 0.82709 5  0.037257  0.2736    – 
   Coefficient   Standard Error  Test Statistic   p-value 
(Intercept)   -116.514      497.305    -0.234      0.816 
AMI ~ TOMM2          4.459        9.951     0.448      0.657 
 
(Intercept)    1432.49       704.85     2.032     0.0495  
VMI ~ TOMM2         -26.54        14.10     -1.882     0.0680  
 
(Intercept)    559.973      606.256     0.924      0.362 
VWMI ~ TOMM2       -9.081       12.131    -0.749      0.459 
 
(Intercept)     726.86       604.15     1.203      0.237 
IMI ~ TOMM2            -12.41        12.09     -1.026      0.312 
 
(Intercept)     635.81       624.22     1.019      0.315 
DMI ~ TOMM2         -10.57        12.49    -0.846      0.403 
* = Significant at 0.0025 level 
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A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the sum of TOMM Trial 1 and Trial 2.   A summation of TOMM 
Trial data was used as a predictor for WMS-IV composite score dependent variables.  WMS-IV 
composite score data consisted of the Auditory Memory Index (AMI), Visual Memory Index (VMI), 
Visual Working Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed Memory 
Index (DMI).  No statistically significant regression equation was found (F(5,32) = 0.047738, p < 
0.9985), with an R
2
 of 0.001484.  Table 14 presents a regression model predicting WMS-IV index 
scores from the summation of TOMM Trial 1 and 2. 
Table 14: Regression model predicting WMS-IV index scores from a summation of TOMM Trial 1and 2 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
ALLT  0.9926  5  0.001484  0.9985   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   53.4283     127.7079     0.418      0.678 
AMI ~ ALLT        0.5345       1.2899     0.414      0.681 
 
(Intercept)   58.3648     189.4557     0.308      0.760 
VMI ~ ALLT        0.4828       1.9135     0.252      0.802 
 
(Intercept)   70.3131     156.7165     0.449      0.656 
VWMI ~ ALLT       0.3621       1.5829     0.229      0.820 
 
(Intercept)   60.8348     157.1465     0.387      0.701 
IMI ~ ALLT        0.4655       1.5872     0.293      0.771 
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(Intercept)   41.1416     161.4405     0.255      0.800 
DMI ~ ALLT        0.6724       1.6306     0.412      0.683 
* = Significant at 0.0025 level 
 
R4 How much variance in the WMS-IV composites does the WMT account for? 
A multivariate linear regression was calculated to predict performance on composite scores 
from the WMS-IV based on performance on the Immediate Recall score of the Word Memory Test 
(WMT). Immediate Recall data was used as a predictor for WMS-IV composite score dependent 
variables.    WMS-IV composite score data consisted of the Auditory Memory Index (AMI), Visual 
Memory Index (VMI), Visual Working Memory Index (VWMI), Immediate Memory Index (IMI), and 
the Delayed Memory Index (DMI).  No statistically significant regression equation was found (F(5,35) 
= 4.4651, p < 0.002988), with an R
2
 of 0.093967.  Table 15 presents a regression model predicting 
WMS-IV index scores from WMT Immediate Recall. 
Table 15: Regression model predicting WMS-IV index scores from WMT Immediate Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
IR  0.61055 5  0.0939967  0.002988  – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)    13.5470      34.4651     0.393     0.6964   
AMI ~ IR             0.9484       0.3513     2.700     .0102  
 
(Intercept)   -28.4390      48.5135    -0.586    0.56111    
VMI ~ IR             1.3658       0.4945     2.762     0.00871 
 
(Intercept)   -37.5060      36.8370    -1.018    0.31488     
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VWMI ~ IR             1.4640       0.3755     3.899     0.00037 
 
(Intercept)   -18.8146      40.5893    -0.464    0.64556    
IMI ~ IR             1.2793       0.4137     3.092     0.00366 
 
(Intercept)   -22.8618      39.4299    -0.580    0.56538    
DMI ~ IR             1.3290       0.4019     3.307     0.00203 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Delayed Recall score of the WMT.  Delayed Recall data was 
used as a predictor for WMS-IV composite score dependent variables.  WMS-IV composite score data 
consisted of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working 
Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No 
statistically significant regression equation was found (F(5,35) = 4.0836, p < 0.005028), with an R
2
 of 
0.087812.  Table 16 presents a regression model predicting WMS-IV index scores from WMT Delayed 
Recall. 
Table 16: Regression model predicting WMS-IV index scores from WMT Delayed Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
DR  0.63157 5  0.087812  0.005028   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   -22.8194      51.9247    -0.439     0.6627   
AMI ~ DR             1.3051       0.5238     2.492     0.0171  
 
(Intercept)   -61.1117      74.3391    -0.822     0.4160   
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VMI ~ DR             1.6807       0.7499     2.241     0.0308  
 
(Intercept)   -105.2151      55.1006    -1.910    0.063573   
VWMI ~ DR              2.1314       0.5558     3.835    0.000447 
 
(Intercept)    -65.265       61.562    -1.060    0.29559    
IMI ~DR              1.734        0.621     2.793     0.00806  
 
(Intercept)   -51.8615      61.3354    -0.846     0.4030   
DMI ~ DR             1.6073       0.6187     2.598     0.0132  
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Consistency score of the WMT.  Consistency score data was 
used as a predictor for WMS-IV composite score dependent variables.  WMS-IV composite score data 
consisted of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working 
Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No 
statistically significant regression equation was found (F(5,35) = 3.2457, p < 0.01641), with an R
2
 of 
0.07336.  Table 17 presents a regression model predicting WMS-IV index scores from WMT 
Consistency. 
Table 17: Regression model predicting WMS-IV index scores from WMT Consistency 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
CNS  0.68321 5  0.07336  0.01641   – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)    13.2823      35.2970     0.376     0.7087   
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AMI ~ CNS            0.9535       0.3607     2.644     0.0118  
 
(Intercept)   -26.5166      49.8504    -0.532     0.5978   
VMI ~ CNS            1.3495       0.5094     2.649     0.0116  
 
(Intercept)   -21.0376      39.3795    -0.534    0.59622    
VWMI ~ CNS            1.2992       0.4024     3.229     0.00252 
   
(Intercept)   -21.3602      41.4394    -0.515    0.60914    
IMI ~ CNS            1.3085       0.4234     3.090     0.00368 
   
(Intercept)   -17.1216      40.9394    -0.418    0.67808    
DMI ~ CNS            1.2736       0.4183     3.045     0.00416 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Multiple Choice score of the WMT.  Multiple Choice score data 
was used as a predictor for WMS-IV composite score dependent variables.  WMS-IV composite score 
data consisted of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working 
Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No 
statistically significant regression equation was found (F(5,35) = 3.9367, p < 0.006162), with an R
2
 of 
0.085376.  Table 18 presents a regression model predicting WMS-IV index scores from WMT Multiple 
Choice. 
Table 18: Regression model predicting WMS-IV index scores from WMT Multiple Choice 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
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MC  0.64005 5  0.085376  0.006162  – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   57.3505      15.2021     3.773    0.000537 
AMI ~ MC             0.5256       0.1618    3.248 0  .002394  
  
(Intercept)   40.0294      21.8032     1.836     0.07400  
VMI ~ MC             0.6993       0.2321     3.013     0.00453 
 
(Intercept)    50.2482      17.6743     2.843     0.00708 
VWMI ~ MC             0.5960       0.1881     3.168     0.00298 
 
(Intercept)    38.8080      17.5619     2.210    0.033058   
IMI ~ MC                   0.7246       0.1869     3.876    0.000396 
 
(Intercept)         45.6556      17.7744     2.569     0.01415  
DMI ~ MC             0.6603       0.1892     3.490     0.00122 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Paired Associates score of the WMT. Paired Associates data 
was used as a predictor for WMS-IV composite score dependent variables.  WMS-IV composite score 
data consisted of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working 
Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI). A 
statistically significant regression equation was found (F(5,35) = 5.7812, p < 0.000543), with an R
2
 of 
0.113446.  The p value reached statistical significance at the 0.0025 (0.05/20) level.  This suggests that 
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WMT Paired Associates scores account for over 11% of the variance in WMS-IV composite scores.  
Table 19 presents a regression model predicting WMS-IV index scores from WMT Paired Associates. 
Table 19: Regression model predicting WMS-IV index scores from WMT Paired Associates 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
PR  0.54768 5  0.113446  0.000543  – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   58.4556      13.8628     4.217   0.000142 
AMI ~ PR             0.5144       0.1477     3.484   0.001235  
   
(Intercept)   34.5508      19.3083     1.789   0.081314   
VMI ~ PR             0.7589       0.2057     3.690   0.000684 
 
(Intercept)   46.8091      15.6955     2.982    0.00491   
VWMI ~ PR             0.6336       0.1672     3.790    0.00051  
 
(Intercept)   38.2889      15.6799     2.442    0.0192    
IMI ~ PR             0.7311       0.1670     4.378   8.71e-05 
 
(Intercept)   40.8229      15.5228     2.630   0.012163   
DMI ~ PR             0.7129       0.1653     4.312   0.000107 
* = Significant at 0.0025 level 
A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Free Recall score of the WMT.  Free Recall data was used as a 
predictor for WMS-IV composite score dependent variables.  WMS-IV composite score data consisted 
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of the Auditory Memory Index (AMI), Visual Memory Index (VMI), Visual Working Memory Index 
(VWMI), Immediate Memory Index (IMI), and the Delayed Memory Index (DMI).  No statistically 
significant regression equation was found (F(5,35) = 2.7719, p < 0.03273), with an R
2
 of 0.064543.  
Table 20 presents a regression model predicting WMS-IV index scores from WMT Free Recall. 
Table 20: Regression model predicting WMS-IV index scores from WMT Free Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
FR  0.71634 5  0.064543  0.03273      – 
   Coefficient   Standard Error  Test Statistic   p-value 
 (Intercept)   86.3778       6.8340    12.639   2.28e-15  
AMI ~ FR             0.3105       0.1030     3.013     0.00453   
 
(Intercept)   83.7589      10.1150     8.281    4.01e-10 
VMI ~ FR             0.3343       0.1525     2.192     0.0344    
  
(Intercept)   91.0308       8.4268    10.803   2.75e-13 
VWMI ~ FR             0.2308       0.1271     1.817      0.077  
 
(Intercept)    84.5619       8.4125    10.052   2.21e-12 
IMI ~ FR             0.3396       0.1268     2.677      0.0108    
   
(Intercept)    83.3092       8.1064    10.277   1.17e-12 
DMI ~ FR             0.3717       0.1222     3.041     0.0042   
* = Significant at 0.0025 level 
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A multivariate linear regression was calculated to predict performance on composite scores from the 
WMS-IV based on performance on the Long Delayed Free Recall score of the WMT.  Long Delayed 
Free Recall score data was used as a predictor for WMS-IV composite score dependent variables.  
WMS-IV composite score data consisted of the Auditory Memory Index (AMI), Visual Memory Index 
(VMI), Visual Working Memory Index (VWMI), Immediate Memory Index (IMI), and the Delayed 
Memory Index (DMI).  No statistically significant regression equation was found (F(5,35) = 1.7933, p 
< 0.1398), with an R
2
 of 0.044591.  Table 21 presents a regression model predicting WMS-IV index 
scores from WMT Long Delayed Free Recall. 
Table 21: Regression model predicting WMS-IV index scores from WMT Long Delayed Free Recall 
Variable Wilks  DVs  Overall r-squared Pr(>F)  Significant at 0.0025 
LDFR  0.79605 5  0.044591  0.1398   – 
   Coefficient   Standard Error  Test Statistic   p-value 
(Intercept)    86.2472       7.0675    12.203   6.83e-15 
AMI ~ LDFR           0.3070       0.1048     2.929     0.00566   
 
(Intercept)    88.0971      10.6573     8.266    4.19e-10 
VMI ~ LDFR           0.2628       0.1581     1.662      0.105     
 
(Intercept)     94.581        8.833     10.71    3.57e-13 
VWMI ~ LDFR           0.173        0.131      1.32       0.194     
 
(Intercept)    84.9785       8.7280     9.736    5.42e-12 
IMI ~ LDFR           0.3274       0.1295     2.529     0.0156    
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(Intercept)    87.1497       8.6634    10.060   2.16e-12 
DMI ~ LDFR           0.3070       0.1285     2.389      0.0218    
* = Significant at 0.0025 level 
Means of Variables 
R5 Does the examination of the means of all variables in the obtained sample look comparable to the 
means found in the literature? 
 The mean, standard deviation, and range for each WMS-IV, TOMM, and WMT variable is 
presented in Table 22 and Table 23.   
Table 22: Mean, Standard Deviation, and Range Statistics for the WMS-IV 
Variable      Mean  SD  Min  Max 
WMS-IV Subtests 
Logical Memory I     11.58  2.39  3  15 
Logical Memory II     10.98  2.20  5  15 
Verbal Paired Associates I    10.71  2.19  3  14 
Verbal Paired Associates II    11.16  1.82  4  13 
Designs I      11.24  2.81  5  19 
Designs II      11.16  2.70  6  17 
Visual Reproduction I    10.36  2.76  4  14 
Visual Reproduction II    10.64  2.85  6  17 
Spatial Addition     10.57             2.67                1  14                         
Symbol Span      11.50  2.10  7  16 
Designs I Content     11.36  2.25  6  17 
Designs I Spatial     10.66  3.25  5  17 
Designs II Content     11.34  2.51  3  18 
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Designs II Spatial     10.45  3.05  6  17 
WMS-IV Composites            
Auditory Memory Index    106.30  9.92  78  126 
Visual Memory Index    105.09  13.93  73  132 
Visual Working Memory Index   106.21  11.42  63  126 
Immediate Memory Index    106.78  11.94  72  130 
Delayed Memory Index    106.93  11.93  72  128  
Note. Subtests have a mean of 10 and SD of 3.  Composites have a mean of 100 and SD of 15. 
 
Table 23: Mean, Standard Deviation, and Range Statistics for the TOMM and WMT 
Variable      Mean  SD  Min  Max 
WMT Scores 
Immediate Recognition    98.07  4.07  78  100 
Delayed Recognition     98.95  2.91  83  100 
Consistency      97.82  4.01  80  100 
Multiple Choice     93.18  9.65  65  100 
Paired Associates     93.07  10.24  60  100 
Free Recall      64.59  14.22  35  100 
Long Delay Free Recall    65.66  13.77              38  95                         
TOMM Scores 
Trial I       48.98  1.31   
Trial II       49.98  0.16   
Sum of Trial I and II     98.95  1.30   
Note.  WMT scores reported as percentage correct.  TOMM scores reported as raw scores. 
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Correlation Results 
R6 How much correlation is present between TOMM and WMT scores? 
 Correlations between TOMM and WMT scores were calculated.  Two methodologies for 
computing correlations were performed.  Pearson correlations were obtained as this is a commonly 
used method for assessing the strength of a linear association between two variables.  Spearman 
correlations were obtained in addition to Pearson correlations as Spearman correlations are rank-order 
correlations that are considered by some researchers to be a better methodology for analyzing data that 
does not adhere to a normal distribution (Merten, Bossink, & Schmand, 2007).  In the present study, the 
obtained TOMM and WMT scores do not appear to be normally distributed.  Pearson correlations and 
Spearman correlations are presented in Table 24 and Table 25.                                                                                                                                                                          
Table 24: Pearson correlations between the TOMM and WMT 
Variable   1 2 3 4 5 6 7 8 9 10 
WMT Scores 
1. Immediate Recognition ---  
2. Delayed Recognition 0.77† ---  
3. Consistency  0.97† 0.77† ---  
4. Multiple Choice  0.56† 0.63† 0.61† ---  
5. Paired Associates  0.63† 0.67† 0.67† 0.92† ---  
6. Free Recall   0.34* 0.45† 0.40† 0.54† 0.56† ---  
7. Long Delay Free Recall 0.19 0.28 0.26 0.47† 0.44† 0.80† ---  
TOMM Scores 
8. Trial I   0.17 0.14 0.15 0.02 0.03 -0.13 -0.14 ---  
9. Trial II   -0.08 -0.06 -0.09 -0.12 -0.11 -0.24 -0.29 -0.12 ---  
10. Sum of Trial I and II 0.17 0.13 0.14 0.01 0.01 -0.16 -0.18 0.99† -0.01 ---  
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† = Significant at 0.01  * = Significant at 0.05 
Table 25: Spearman correlations between the TOMM and WMT 
Variable   1 2 3 4 5 6 7 8 9 10 
WMT Scores 
1. Immediate Recognition --- 
2. Delayed Recognition 0.50† --- 
3. Consistency  0.90† 0.60† --- 
4. Multiple Choice  0.46† 0.47† 0.56† --- 
5. Paired Associates  0.46† 0.44† 0.57† 0.84† --- 
6. Free Recall   0.17 0.45† 0.32* 0.58† 0.53† --- 
7. Long Delay Free Recall 0.17 0.39† 0.29 0.61† 0.55† 0.78† --- 
TOMM Scores 
8. Trial I   0.25 0.09 0.21 0.12 0.11 0.01 -0.08 --- 
9. Trial II   -0.13 -0.09 -0.13 -0.15 -0.16 -0.26 -0.24 -0.16 --- 
10. Sum of Trial I and II 0.23 0.07 0.19 0.09 0.07 -0.05 -0.13 0.98† 0.06 --- 
† = Significant at 0.01  * = Significant at 0.05 
R7 How much correlation is present between WMS-IV, TOMM, and WMT scores? 
 Pearson correlations were used to explore the relationship between WMS-IV and TOMM as 
well as between the WMS-IV and WMT.  Results from WMS-IV, TOMM, and WMT correlations are 
presented in Table 26 and Table 27.  
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Table 26: Pearson correlations between the WMS-IV and TOMM 
Variable    1 2 3 4 5 6 7 8   
WMS-IV Composites 
1. Auditory Memory    ---       
2. Visual Memory   0.47† --- 
3. Visual Working Memory  0.19 0.50† --- 
4. Immediate Memory  0.80† 0.85† 0.47† --- 
5. Delayed Memory   0.75† 0.88† 0.40† 0.85† --- 
TOMM Scores 
6. Trial I    0.01 0.05 0.07 0.05 0.05 --- 
7. Trial II    0.07 -0.30 -0.12 -0.16 -0.14 -0.12 --- 
8. Sum of Trial I and II  0.02 0.01 0.05 0.03 0.03 0.99† -0.01 --- 
† = Significant at 0.01  * = Significant at 0.05 
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Table 27: Pearson correlations between the WMS-IV Composites and the WMT 
Variable 1 2 3 4 5 6 7 8 9 10 11 12 
WMS-IV Composites 
1. AMI ---  
2. VMI 0.47† --- 
3. VWMI 0.19 0.50† ---  
4. IMI  0.80† 0.85† 0.47† ---  
5. DMI 0.75† 0.88† 0.40† 0.85† ---  
WMT Scores 
6. IR  0.40† 0.41† 0.53† 0.44† 0.46† ---  
7. DR  0.40† 0.35* 0.51† 0.41† 0.42† 0.75† ---  
8. CNS 0.41† 0.40† 0.46† 0.46† 0.45† 0.94† 0.82† --- 
9. MC  0.49† 0.44† 0.46† 0.54† 0.51† 0.58† 0.66† 0.64† --- 
10. PR  0.51† 0.51† 0.53† 0.58† 0.58† 0.65† 0.69† 0.69† 0.92† --- 
11. FR  0.46† 0.34* 0.29 0.43† 0.46† 0.34* 0.44† 0.40† 0.54† 0.56† ---  
12. LDFR 0.44† 0.27 0.22 0.39† 0.37* 0.19 0.28 0.26 0.47† 0.44† 0.80† --- 
† = Significant at 0.01  * = Significant at 0.05 
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Chapter V 
DISCUSSION 
 
Discussion 
 This chapter is divided into 4 sections:  summary of the study, discussion of the results, 
limitations and delimitations of the study, and directions for future research.   
Purpose of the study.  The purpose of this study was to explore the relationship between a 
well-validated measure of memory and commonly used symptom validity tests in neuropsychology.  
Specifically, this study examined how performance on the Test of Memory Malingering (TOMM; 
Tombaugh, 1996) and Word Memory Test (WMT; Green, 2003) was related to performance on the 
Wechsler Memory Scale, Fourth Edition (WMS-IV; Wechsler, 2009).  This study also explored the 
relationship within and between the TOMM and the WMT.  Data for this study came from 46 students 
attending a psychology class at a Midwestern university.  These students were instructed to provide full 
effort for the entirety of their session and were offered research participation credit regardless of 
completion of all tasks.  Student demographics and performance were largely consistent with what 
would be expected for a Midwestern university sample.  Students were interviewed for demographic 
information, administered measures of memory and symptom validity as well as other related 
assessments for a larger study.  Students typically completed all tasks in nearly 4 hours and were not 
held past 4 hours.   
  
SYMPTOM VALIDITY AND MEMORY 
 
134 
 
 A total of 20 multivariate regression analyses were used to address 4 research questions 
examining the relationship between the WMS-IV, TOMM or WMT.  An alpha of 0.0025 was selected 
due to necessity of using a Bonferroni correction.  A Bonferroni correction was selected due to it being 
regarded as a conservative method for avoiding Type I errors (Dunn, 1961).  Normality and linearity of 
data were examined by Q-Q Plots and Mardia tests of multivariate skew and kurtosis (Mardia, 1970). 
Spearman and Pearson correlations were used to examine the relationship between the TOMM 
and WMT.  A Spearman correlation was conducted in addition to a Pearson correlation as Spearman 
correlations are rank-order correlations that are considered by some researchers to be better suited to 
data that does not align with a normal distribution (Merten, Bossink, & Schmand, 2007).  It is typical 
for adults who take symptom validity tests who are not feigning impairment to provide restricted 
ranges of data on symptom validity indicators, such as the TOMM (Hill, Laurie, Kennedy, & Malamut, 
2003; Morgan & Sweet, 2008; Brooks, Sherman, & Krol, 2012).  This pattern of restricted ranges of 
data on the TOMM and WMT was observed in the present study. 
Means, standard deviations, and frequencies of demographic characteristics were computed.  
All calculations and statistical analyses were performed in R i386 3.3.2 (R Core Team, 2013) with 
relevant add-on packages. 
Discussion of the results.  Upon examination of the data obtained in this study and 
examination of relevant literature (Hill, Laurie, Kennedy, & Malamut, 2003; Morgan & Sweet, 2008; 
Brooks, Sherman, & Krol, 2012), it was clear that patterns of data could hinder usage of common 
parametric statistics.  The symptom validity tests generally showed a restricted range in performance.  
For example, on TOMM Trial 2 the mean was 49.98 and the standard deviation was 0.16.  Given the 
symptom validity tests should be easily completed by the vast majority of participants who are not 
feigning impairment, the restricted range of performance was expected and the reduced variability 
makes finding a relationship between effort and memory measures less likely.  It is important to note 
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that the lack of a significant relationship is useful for clinicians as these tests should be measuring 
unrelated constructs.  A discussion of the statistical analyses for each research question is presented 
below.     
WMS-IV subtest variance accounted for by the TOMM.  A multivariate regression was used to 
explore how well TOMM Trial 1 and Trial 2 could account for variance in WMS-IV subtests.  In the 
present study and in many clinical applications, data on TOMM Trial 1 and Trial 2 are available, so a 
summation of both trials was also calculated in an effort to increase the variability and possibly other 
statistical properties (e.g. reliability).  This effort did not make meaningful improvements in variability 
for the present study.  The unsuccessful attempts to mathematically increase chances of a relationship 
between the TOMM and WMS-IV reinforce the idea that the TOMM and WMS-IV are measuring 
unrelated constructs. 
 The scores obtained from the TOMM were used as predictors for performance on WMS-IV 
subtests during these analyses.  For TOMM Trial 1, no statistically significant regression equation was 
found (F(16,21) = 1.2745, p < 0.2959), with an R
2
 of 0.041523.  For TOMM Trial 2, no statistically 
significant regression equation was found (F(16,21) = 0.89061, p < 0.5877), with an R
2
 of 0.031853.  
For the summation of TOMM Trial 1 and Trial 2, no statistically significant regression equation was 
found (F(16,21) = 1.3988, p < 0.2326), with an R
2
 of 0.04433.  Since 20 separate regressions were 
conducted, an alpha level of 0.0025 instead 0.05 was used.  Adjusting the alpha level through a 
Bonferroni correction is a conservative way to reduce chances for Type I errors.   
 These results have several implications for researchers and clinicians.  The results suggest that 
the TOMM will likely not be predictive of performance on measures of memory, especially in a 
population resembling the sample for this study.  This suggests that for individuals passing symptom 
validity indicators, the results of administered memory measures will very likely be autonomous from 
symptom validity indicator performance.  From a perspective of construct validity, the TOMM being 
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independent from the subtests on the WMS-IV is reassuring as these tests were designed to measure 
different constructs.  The present study; however, does not show if the TOMM and WMS-IV would be 
related in samples providing suboptimal performance and the results may be different from clinical 
populations or individuals of different ages.   
WMS-IV subtest variance accounted for by the WMT.  A multivariate regression was used to 
explore if WMT scores account for variance in WMS-IV subtests.  A total of 7 WMT scores were used 
to predict WMS-IV subtest performance.  No statistically significant regression equation was found for 
any of the WMT scores: WMT Immediate Recall (F(16,24) = 1.4183, p < 0.2137, R
2
 = 0.040743), 
WMT Delayed Recall (F(16,24) = 1.9006, p < 0.07522, R
2
 = 0.049869), WMT Consistency (F(16,24) 
= 1.2062, p < 0.3305, R
2
 = 0.03621), WMT Multiple Choice (F(16,24) = 2.2879, p < 0.03247, R
2
 = 
0.056252), WMT Paired Associates (F(16,24) = 2.0906, p < 0.04972, R
2
 = 0.053092), WMT Free 
Recall (F(16,24) = 1.4305, p < 0.2083, R
2
 = 0.040994), and WMT Long Delayed Free Recall (F(16,24) 
= 0.86505, p < 0.6108, R
2
 = 0.028057). 
 While WMT scores were not predictive of WMS-IV scores, it was apparent that some of the 
WMT scores designed to measure memory (e.g. Paired Associates and Multiple Choice) rather than 
effort would have been significant without the application of a Bonferroni correction.  Statistical 
significance would have been a reasonable finding given task similarity; however, the sheer number of 
analyses conducted raises the probability of Type I errors and changes the threshold for concluding 
statistical significance.   
 The implications of the findings of the predictive value of WMT scores for WMS-IV 
performance are similar to findings for the relationship between the TOMM and WMS-IV.  The WMT 
and WMS-IV are designed to measure mostly different constructs.  The autonomy of the WMT 
symptom validity measures from the WMS-IV reassures the clinician and researcher that the 
performance on a symptom validity indicator is not typically affected by participants’ genuine level of 
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functioning.  As noted in the discussion of the previous research question, the current study does not 
address if the relationship between the WMT and WMS-IV would change with a sample providing 
suboptimal performance, different ages, or clinical populations. 
WMS-IV composite variance accounted for by the TOMM.  A multivariate regression was 
used to explore how well each TOMM Trial 1 could account for variance in WMS-IV composite scores 
and how well TOMM Trial 2 could account for variance in WMS-IV composite scores.  A summation 
of TOMM Trial 1 and Trial 2 was utilized for this analysis for the reasons stated in the first research 
question.  An exploration of how well the TOMM accounts for WMS-IV composite score variance was 
conducted in addition to exploring the relationship between the TOMM and WMS-IV subtests as 
composite scores have different statistical properties than the individual subtests from which they are 
comprised, such as reliability, and other attributes desirable for clinicians and researchers. 
The scores obtained from the TOMM were used as predictors for performance on WMS-IV 
composites during these analyses. For TOMM Trial 1, no statistically significant regression equation 
was found (F(5,32) = 0.058231, p < 0.9976), with an R
2
 of 0.001811.  For TOMM Trial 2, no 
statistically significant regression equation was found (F(5,32) = 1.338, p < 0.2736), with an R
2
 of 
0.037257.  For the summation of TOMM Trial 1 and Trial 2, no statistically significant regression 
equation was found (F(5,32) = 0.047738, p < 0.9985), with an R
2
 of 0.001484. 
The relationship between the TOMM and WMS-IV composites appear to be similar or even 
weaker than the relationship between the TOMM and WMS-IV subtests.  Given increased reliability of 
WMS-IV composites compared to WMS-IV subtests, these findings increase confidence that the 
TOMM and WMS-IV were not related in the present sample. 
WMS-IV composite variance accounted for by the WMT.  A multivariate regression was used 
to explore how well each WMT score could account for variance in the WMS-IV composite scores.  As 
with the exploration of the WMS-IV composite and TOMM relationship, the relationship between the 
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WMT and WMS-IV composite scores would be expected to be more reliable than the relationship 
between the WMT and WMS-IV subtest scores.   
The scores obtained from the WMT were used as predictors for performance on WMS-IV 
composites during these analyses. For the WMT Immediate Recall score, no statistically significant 
regression equation was found (F(5,35) = 4.4651, p < 0.002988), with an R
2
 of 0.093967.  For the 
WMT Delayed Recall score, no statistically significant regression equation was found (F(5,35) = 
4.0836, p < 0.005028), with an R
2
 of 0.087812.  For the WMT Consistency score, no statistically 
significant regression equation was found (F(5,35) = 3.2457, p < 0.01641), with an R
2
 of 0.07336.  For 
the WMT Multiple Choice score, no statistically significant regression equation was found (F(5,35) = 
3.9367, p < 0.006162), with an R
2
 of 0.085376.  For the WMT Paired Associates score, a statistically 
significant regression equation was found (F(5,35) = 5.7812, p < 0.000543), with an R
2
 of 0.113446.  
For WMT Free Recall score, no statistically significant regression equation was found (F(5,35) = 
2.7719, p < 0.03273), with an R
2
 of 0.064543.  For the WMT Long Delayed Free Recall, no statistically 
significant regression equation was found (F(5,35) = 1.7933, p < 0.1398), with an R
2
 of 0.044591. 
In the exploration of the WMT and WMS-IV composite scores, the WMT Paired Associates 
test predicted about 11% of variance in WMS-IV composite scores.  With most WMT scores being 
unrelated to WMS-IV performance, it may be most conservative to conclude that the WMT does not 
serve as a good predictor of WMS-IV performance in this population. 
Examination of the means of all variables and comparison to means found in the literature.  
When previous data on measures exists, it is important and interesting to see how data from a sample of 
participants compares to data reported from other researchers.  In general, the mean scores of the 
sample fell close to available normative  means and thus was considered largely representative of what 
would be expected from this university sample.  Normative data is readily available in the literature for 
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the TOMM, WMT, and WMS-IV (e.g. Tombaugh, 1997; Rienstra, Spaan, & Schmand, 2009, 
Wechsler, 2009). 
Correlation between TOMM and WMT scores.  Pearson and Spearman correlations were used 
to explore the strength of correlations between TOMM and WMT scores.  Spearman correlations were 
conducted in addition to Pearson correlations as these correlations are rank-order correlations and may 
be more resilient to non-normal data distributions such as what is found in TOMM and WMT 
distributions (Merten, Bossink, & Schmand, 2007).   
Pearson and Spearman correlations were generally in agreement; however, the Spearman 
correlations were often lower.  The correlations generally adhered to expected patterns.  Immediate 
Recognition, Delayed Recognition, and Consistency on the WMT had strong correlations with one 
another based upon Cohen’s (1988) guidelines.  Multiple Choice, Paired Associates, Free Recall, and 
Long Delayed Free Recall also generally had strong correlations with one another.  Correlations 
between the first three WMT scores and the other WMT scores generally had moderate correlations.  
This is not surprising as these tests are similar yet are intended to measure different constructs.   
The TOMM scores had nearly perfect correlations or what appeared to be weak inverse 
correlations.  All TOMM scores are intended to measure the same construct, so this pattern of data may 
initially appear surprising.  The correlation findings demonstrate the importance of examining data (e.g. 
viewing scatterplots) and reviewing assumptions prior to using correlation analysis and prior to making 
any final conclusions.  Correlational data can easily hide non-linear data patterns, subgroups present in 
the data, and potential data abnormalities (Bewick, Cheek, & Ball, 2003).   
Correlation between WMS-IV composite scores, TOMM scores, and WMT scores.  Pearson 
correlations were conducted to explore if there was a relationship between WMS-IV composite scores 
and scores from the TOMM and WMT.  Specifically, a relationship between visual memory tests and 
the TOMM as well as a relationship between verbal memory tests and the WMT was examined.   
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All correlations between the TOMM and the WMS-IV composites were small or weak based 
upon Cohen’s (1988) guidelines with the exception of a moderate inverse correlation between TOMM 
Trial 2 and the Visual Memory Index of the WMS-IV.  This suggests that performance on the TOMM 
does not have a relationship with visual or verbal composites of the WMS-IV for this sample.  The sole 
moderate inverse correlation was interesting, but was attributed to being a product of the non-normal 
TOMM data used in the study.  If this relationship was a genuine relationship, it would suggest that a 
higher performance on the TOMM Trial 2, specifically, would be related to a lower performance on the 
visual memory subtests of the WMS-IV.   
All correlations between the WMT and WMS-IV composites were in the moderate to large 
range with two exceptions barely being below the moderate range.  Patterns of the WMT being more 
strongly related to any specific WMS-IV composites were not found.  As with the exploration of the 
relationship between the TOMM and WMS-IV, the data suggests that the WMT is not more strongly 
related to WMS-IV tasks that appear similar in presentation than other WMS-IV tasks. 
What is perhaps most interesting from these analyses is that correlations were present between 
WMT and WMS-IV composites.  This suggests that a higher performance on the WMT is related to a 
higher performance on WMS-IV composites.  In some cases, the WMT symptom validity scores are 
more highly correlated with the WMS-IV than WMT memory scores.  For example, the Visual 
Working Memory Index from the WMS-IV and the Immediate Recall score from the WMT have a 
correlation of 0.53 whereas the Visual Working Memory Index and Long Delayed Free Recall score 
from the WMT have a correlation of 0.22.  Upon review of the WMT and WMS-IV relationship 
explored through regression, it appears that the regression would have detected significant 
relationships; however, application of the Bonferroni correction leads to more stringent criteria and 
determinations of nonsignificance.    Stringent criteria, such as a straightforward Bonferroni correction 
can be applied and provide effective protection from Type I errors; however, it remains debatable if a 
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Bonferroni correction would be too strict.  Significant literature has been produced discussing multiple 
comparison problems.  For example, Lindquist and Mejia (2015), explore using appropriate corrections 
during multiple comparisons.  Lindquist and Mejia suggest that in cases where comparisons are not 
completely independent, a Bonferroni correction, can be too strict.  In the present study, many of the 
comparisons are clearly not independent.  One example is in the composition of WMS-IV composite 
scores.  Some WMS-IV composite scores are based on overlapping subtests.  Even when there is not 
clear overlap, one can intuitively conclude that individually measured domains of memory would not 
be independent.   
Limitations 
 The current study had a number of limitations that could impact generalizability.  For example, 
the sample was derived from a nonclinical Midwestern university population.  It is plausible that 
clinical populations may exhibit greater variability in memory performance and symptom validity 
performance.  Since limited variability was present in the present study, a greater variability of 
performance in a clinical population may elucidate stronger relationships between memory and 
symptom validity performance.   
 The present study did not utilize experimental research methodology.  An experimental or 
quasi-experimental study with participants assigned to separate conditions would allow for greater 
confidence in results and greater confidence in explaining obtained data.  For example, studies such as 
those performed by Suhr and colleagues (e.g. Suhr & Gunstad, 2000; Suhr, Gunstad, Greub, & Barrash, 
2004) assigned participants to groups instructed to provide full effort, to feign memory impairment, or 
to feign memory impairment after coaching.  Performance differences in experimental groups can often 
be attributed to the condition or conditions manipulated in the study.  The present study did not allow 
for these type of between-group or within-group comparisons; all participants were given instructions 
to provide full effort.   
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 The present study had a modest sample size of 46 participants.  Ideally, regression analyses 
should have hundreds, if not thousands, of participants in many cases (Knofczynski & Mundfrom, 
2008).  Using additional groups for experimental conditions would have required an even larger 
number of participants for confident statistical interpretation.  Recruiting and administering 
assessments to additional participants is potentially burdensome for small research teams.  Indeed the 
assessment administration time alone for 46 participants required approximately 184 hours of time.   
 An additional important consideration for research is diversity of the sample.  The sample in the 
present study had a nearly equal representation of men (46%) and women (54%), but other sample 
demographics stray farther from the ideal sample.  The present sample consisted solely of 
undergraduate students at one Midwestern university which limits generalizability to similar groups. To 
increase generalizability additional samples would consist of participants with varying education levels, 
ages, and geographic diversity.  Including participants from more settings across a wider geographic 
region may make the ethnic diversity of the sample match the general population.  The present study, 
for example, included two participants (4%) who identified as Hispanic or Latino.  As of 2016, about 
17.8% of the United States population identified as Hispanic or Latino (U.S. Census Bureau, 2016).  
Further consideration of the diversity of functioning in the sample is also important for generalizability.  
For example, the present sample had 9% of participants self-reporting ADHD.  Meta-analyses in the 
literature, such as the one presented by Simon, Czobor, Bálint, Mészáros, and Bitter (2009), suggests 
that adult ADHD prevalence is 2.5% with a range of 1 to 7.3%.  The present sample is somewhat larger 
than this; however, the small sample size, reasonably strong representation of males, and young 
adulthood ages of the present sample make the present findings reasonable.   
Delimitations 
 The present study has a number of strengths that increase applicability to research and clinical 
settings.  The current study utilizes memory and symptom validity measures that have already been 
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carefully designed, studied, and used in research and clinical applications.  The WMS-IV is one of the 
most popular measures of memory used in clinical settings (Rabin, Paolillo, & Barr, 2016).  The 
TOMM is regarded as the most widely used and studied symptom validity indicator (Jelicic, Ceunen, 
Peters, &amp; Merckelbach, 2011).  The WMT is a symptom validity indicator that has numerous 
validation studies on clinical samples (Green, Lees-Haley, & Allen, 2003).  
 The measures utilized in the present study are appropriate for the sample used.  The literature 
suggests that the symptom validity indicators used in the present study are not significantly impacted 
by ability levels.  For example, the WMT has been shown to be insensitive to all but most extreme 
impairments in learning and memory (Flaro, Green, & Robertson, 2007).  Although the present 
university student sample had memory functioning that was modestly higher than the mean (e.g. WMS-
IV Auditory Memory Index mean = 106.30), it is likely that symptom validity performance for a 
nonclinical population with similar demographics instructed to provide full effort would yield similar 
data. 
 The present study utilized a university sample.  Although this sample differs from a clinical 
sample, it also presents some of its own strengths.  For this particular sample, there is no known 
incentive to malinger.  This fact means that the findings of this study is likely applicable to other 
research and clinical populations with no known incentive to malinger.  The present university sample 
also has a fairly consistent level of education (mean years of education = 13.00, standard deviation = 
1.30) and known correlates of ability such as SAT scores.  The findings of this study can be regarded as 
being generalizable to other non-clinical adult populations with average to above average educational 
attainment and abilities.  The literature suggests that the symptom validity tests used in this study are 
resilient to educational and ability level, so findings of this study may be applicable to populations with 
more variance in these domains.  Researchers, such as Banerjee and Chaudhury (2010), caution that 
results from samples should only be generalized to populations that sample was taken from; however, it 
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has been established these measures as performing similarly across age and ability levels.  Green and 
Flaro (2003), for example, have demonstrated that even children can pass the WMT if they have a 3rd 
grade reading level.  Hill, Laurie, Kennedy, and Malamut (2003) have demonstrated that the TOMM 
can be passed with by individuals with temporal lobe dysfunction.   
The present study consisted assessments that took approximately four hours to administer.  
Initially, a lengthy assessment can present as a weakness as participants and examiners could 
experience fatigue effects; however, the length of the assessment adds to the ecological validity of the 
study.  Multiple assessments are often given during clinical neuropsychological examinations which 
can result in sessions spanning several hours.  Symptom validity tests were interspersed in the present 
study which was consistent with how these tests are designed to be administered.  In addition, test 
batteries were administered in the same order for each participant. 
 
Future Directions 
 The present research addresses some questions related to the relationships between symptom 
validity measures and memory measures; however, there are a number of avenues available for future 
research.  Some studies (e.g. Suhr & Gunstad, 2000; Suhr, Gunstad, Greub, & Barrash, 2004) have 
experimental conditions in which some participants are instructed to malinger, some participants are 
instructed to malinger and given coaching, and some participants are instructed to provide full effort.  
Adding experimental conditions to a study similar to the present study could add a number of 
significant strengths.  Researchers could determine if symptom validity indicators hold the same 
relationship with memory measures in a variety of conditions.  With some participants providing 
suboptimal effort, it would be likely that some participants would fail symptom validity tests and 
provide greater variability in scores for both symptom validity tests and memory measures.  The greater 
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variability in scores could potentially lead to more normal distributions in data and the ability to apply 
different statistical tests.   
 The addition of experimental conditions in which participants are instructed to malinger could 
also build confidence in the application of research findings to clinical populations.  In some referred 
populations, participants might provide suboptimal effort and possibly fail symptom validity indicators.  
Referred populations may be seeking external incentives via successful malingering whereas 
experimental research samples may not have strong incentives to malinger.   
 Future studies could also include samples from clinical populations and not just university 
populations.  Clinical samples used in future research could include participants with diversity in age, 
ability, referral concerns, and incentives to malinger.  This would result in larger sample sizes as data 
could be pulled from cases spanning years.  Of course, this would likely limit opportunities for 
experimental manipulations and reasonable certainties of incentives provided and effort given.   
 Future studies may benefit from usage of other types of statistics and corrections that are 
available or may become available.  A larger sample size with more variance in performance could 
open more doors for statistical methods and applications of mathematical data transformations could 
allow for data to better meet assumptions for statistical analysis.  Future studies could also include 
explorations of different memory and symptom validity indicators. 
 The present study looked at predicting memory performance based upon symptom validity test 
performance.  It may be more useful to clinicians to reverse predictive directionality.  Clinicians may 
routinely use memory or related cognitive assessments and could ponder whether or not symptom 
validity tests should be administered.  Indeed, some embedded measures predicting symptom validity 
based on memory or cognitive assessment performance already exist.  Simple embedded measures such 
as Reliable Digit Span (RDS) have been found to be strongly related to symptom validity tests and 
more useful than other available embedded measures (Miele, Gunner, Lynch, & McCaffrey, 
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2012).Further improvement of embedded measures could shorten overall assessment time and 
expenditures and provide confidence in validity of obtained data. 
Summary of Implications for Clinical Practice and Future Research 
 The present study suggests that for individuals providing adequate effort during assessments, it 
is unlikely that memory performance can be predicted based upon symptom validity performance.  
Symptom validity tests, such as those employed in this study, are typically designed to appear as 
difficult memory tests but are easily passable in reality.  In the present sample and likely in many 
populations, participants providing adequate effort during assessments obtain passing scores on 
symptom validity tests.  Memory assessments often allow for precise measurement of a wide variety of 
performances in clinical and healthy research samples.  A variety of scores cannot typically be 
predicted from scores that do not vary.  Metaphorically, intensity of light in every room of a university 
cannot be predicted based upon knowledge that every light switch is completely turned on. 
 For clinical and research settings, the data suggests that symptom validity test performance is 
not predictive of performance on memory tests.  It may, however, be possible to use embedded 
symptom validity measures in memory tests to predict performance.  Again revisiting the metaphor 
above, it may be possible in some situations to predict if a light switch is turned off based upon the 
intensity of light measured in a room.  For the foreseeable future, one of the best ways to measure 
symptom validity during an examination is to use the TOMM or WMT or another measure specifically 
designed for this purpose.  One of the best ways to measure memory performance is also to administer 
the WMS-IV or another measure specifically designed for this purpose.   
 Data from the present study suggests that scores from one symptom validity indicator are not 
effectively comparable with scores from another symptom validity indicator via correlation for the 
current sample under study.  Correlation and a number of statistical methods do not work as expected 
when assumptions, such as normality of data, are not well satisfied.  In clinical settings, in particular, it 
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may be most important to simply know if adequate effort is given (binary data) rather than a very 
specific measurement of symptom validity given at that point in time (continuous data).  Comparisons 
between symptom validity indicators, should therefore, focus on agreement rates (binary data) when 
comparisons of continuous data from these measures is not possible for statistical or theoretical 
reasons.   
Summary of the Study 
 The sample obtained for this study had fairly unremarkable differences in performance 
compared to what would be expected based upon the norms available for memory and symptom 
validity measures utilized for this study.  Given the sample was college students rather than a sample 
from the general population, the small positive skew found on memory measure performance was not 
particularly noteworthy.  Effort test results had a restricted range of data.  While problematic for 
statistical analysis, the restricted range of data for symptom validity tests suggests valid administration 
of the research protocol.   
 The regression analyses conducted during this research showed that a number of memory and 
symptom validity variables were related; however, the sheer number of analyses conducted increased 
likelihood of false positive results.  One conservative option for correcting for false positives, is the 
Bonferroni correction.  After application of this simple correction, there were still some significant 
results such as the relationship between all WMT scores and the WMS-IV composite scores.  While 
this is interesting, careful examination of data patterns suggested that assumptions for usage of 
regression were violated.  With this in mind, it is likely that false positive results are still possible.  
Logarithmic data transformations may prove successful in improving data linearity; however, the 
extremely restricted range of symptom validity test performance likely cannot be corrected 
mathematically and therefore trumps all other concerns.   
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Correlational data between symptom validity indicators was also problematic due to non-
normal data patterns.  Similar to the findings of the regression analyses, the restricted range of 
performance on symptom validity indicators presented difficulties for both types of attempted 
correlational analyses.  Well-known methods of statistical analysis are not effective when assumptions 
for the data are violated.  Indeed the best chance of getting usable statistical information is careful 
research design and consideration of the research questions.   
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